Marketing Authorisation 53128 for MedicinalProductDefinition 8cbcfc42-2c47-4f5f-857f-5cf9bfb385c3

Femoston Tabl 2/10 mg 28 Stk

Marketing Authorisation 53128033-0ab724b8-cfd6-482e-94b6-d9a9bead48cd for PackagedProductDefinition 0ab724b8-cfd6-482e-94b6-d9a9bead48cd

Reimbursement SL ddc8a0e3-aeea-4bc9-9417-c52bdca3494a for PackagedProductDefinition 0ab724b8-cfd6-482e-94b6-d9a9bead48cd

Estradiolum

Dydrogesteronum


Marketing Authorisation 54986 for MedicinalProductDefinition bf186fa5-6258-4e57-815d-cced47188db2

Femoston conti Filmtabl 0.5/2.5 28 Stk

Medicinal product subject to medical or veterinary prescription (B)

Marketing Authorisation 54986001-d2b70eeb-0142-4c4f-8105-059c3841b04b for PackagedProductDefinition d2b70eeb-0142-4c4f-8105-059c3841b04b

Reimbursement SL 61cf7e9f-dcaf-4fb2-b5c6-0fb0fc3f1422 for PackagedProductDefinition d2b70eeb-0142-4c4f-8105-059c3841b04b

Price mutation after triennal review of pharmaceuticals

Estradiolum

Dydrogesteronum


Marketing Authorisation 54986 for MedicinalProductDefinition bc9d6367-d1dd-483e-bac6-fb5e44d80fe9

Femoston conti Filmtabl 1/5 28 Stk

Marketing Authorisation 54986018-848870c7-4a70-4a40-810b-6bc6a42c73b8 for PackagedProductDefinition 848870c7-4a70-4a40-810b-6bc6a42c73b8

Reimbursement SL 14ccb4ce-f539-4781-a169-4f7a7f2f0621 for PackagedProductDefinition 848870c7-4a70-4a40-810b-6bc6a42c73b8

Estradiolum

Dydrogesteronum


Marketing Authorisation 54888 for MedicinalProductDefinition d01e59bd-2ab0-4ab4-ad5c-c7f2dc8a4676

Femoston mono Filmtabl 2 mg 28 Stk

Marketing Authorisation 54888024-42d42f62-4ae6-4a7a-ac34-c59e95fa25e4 for PackagedProductDefinition 42d42f62-4ae6-4a7a-ac34-c59e95fa25e4

Reimbursement SL a0040577-7819-4b84-8c03-4c67a51b4a0e for PackagedProductDefinition 42d42f62-4ae6-4a7a-ac34-c59e95fa25e4

Estradiolum


Marketing Authorisation 27528 for MedicinalProductDefinition f85185db-bff7-422b-9877-1a8e72172dd7

Feniallerg Tropfen 1 mg/ml 20 ml

Marketing Authorisation 27528075-6cd8302d-3d37-45cf-9a9a-a2910dc4cf32 for PackagedProductDefinition 6cd8302d-3d37-45cf-9a9a-a2910dc4cf32

Reimbursement SL 1183cd1d-c37c-4ab3-8eae-c4708975783a for PackagedProductDefinition 6cd8302d-3d37-45cf-9a9a-a2910dc4cf32

Dimetindeni maleas


Fentanyl (parenterale Formen siehe N01AH01)

Marketing Authorisation 67800 for MedicinalProductDefinition ea251668-6c19-41f6-b258-d66b7085cb82

Fentalis TTS 12 mcg/h 5 Stk

Medicinal product subject to medical or veterinary prescription single dispensation (A)

Fentalis TTS 12 mcg/h 10 Stk

Marketing Authorisation 67800001-237e2427-887a-445c-ab53-95dba97af509 for PackagedProductDefinition 237e2427-887a-445c-ab53-95dba97af509

Reimbursement SL 675f4f5a-80a0-4602-a728-cf2e00f51b89 for PackagedProductDefinition 237e2427-887a-445c-ab53-95dba97af509

Reimbursement SL 53ae480c-386b-4e0b-ae2a-2f7a246d0730 for PackagedProductDefinition e917371c-54d6-44e5-944b-14ba83766431

Fentanylum


Marketing Authorisation 67800 for MedicinalProductDefinition 84edf578-0a17-47b7-8d53-dbf9358a71e8

Fentalis TTS 25 mcg/h 5 Stk

Fentalis TTS 25 mcg/h 10 Stk

Marketing Authorisation 67800003-1a604095-cac5-4676-9154-0e0e2b11838b for PackagedProductDefinition 1a604095-cac5-4676-9154-0e0e2b11838b

Marketing Authorisation 67800004-c7ff9d0b-f20d-4f00-b8aa-8df12dd6f966 for PackagedProductDefinition c7ff9d0b-f20d-4f00-b8aa-8df12dd6f966

Reimbursement SL b9177bdb-b6d1-4577-a7e4-e539fd1a5a07 for PackagedProductDefinition 1a604095-cac5-4676-9154-0e0e2b11838b

Reimbursement SL 9f4d0f70-6990-4160-9d5b-46e3a05c58c0 for PackagedProductDefinition c7ff9d0b-f20d-4f00-b8aa-8df12dd6f966

Fentanylum


Marketing Authorisation 67800 for MedicinalProductDefinition 63253648-898e-4b45-a5bf-24b97a2450e4

Fentalis TTS 37.5 mcg/h 5 Stk

Fentalis TTS 37.5 mcg/h 10 Stk

Marketing Authorisation 67800005-f0d67d81-da95-4c9f-8c4b-d976f8b020e5 for PackagedProductDefinition f0d67d81-da95-4c9f-8c4b-d976f8b020e5

Marketing Authorisation 67800006-ae136557-6daa-48aa-b33e-24f2a63d96a0 for PackagedProductDefinition ae136557-6daa-48aa-b33e-24f2a63d96a0

Reimbursement SL 596b74eb-692f-4454-adbf-faee46a1f33a for PackagedProductDefinition f0d67d81-da95-4c9f-8c4b-d976f8b020e5

Reimbursement SL 4e3a3a4a-848e-4100-8055-f4f029e77c40 for PackagedProductDefinition ae136557-6daa-48aa-b33e-24f2a63d96a0

Fentanylum


Marketing Authorisation 67800 for MedicinalProductDefinition 01529374-028c-46f5-99d9-23ee5c637d64

Fentalis TTS 50 mcg/h 5 Stk

Fentalis TTS 50 mcg/h 10 Stk

Marketing Authorisation 67800007-78895ae2-d3eb-4fc2-8183-ad3e6d3fbb14 for PackagedProductDefinition 78895ae2-d3eb-4fc2-8183-ad3e6d3fbb14

Marketing Authorisation 67800008-f3df2b5c-fc26-493d-aa39-ecb9a03a5e39 for PackagedProductDefinition f3df2b5c-fc26-493d-aa39-ecb9a03a5e39

Reimbursement SL d16b2a47-3d7e-4ee5-9008-1ee8999fc6fb for PackagedProductDefinition 78895ae2-d3eb-4fc2-8183-ad3e6d3fbb14

Reimbursement SL 0594bd86-3b4f-42b1-9e5f-a1f29a95861a for PackagedProductDefinition f3df2b5c-fc26-493d-aa39-ecb9a03a5e39

Fentanylum


Marketing Authorisation 67800 for MedicinalProductDefinition 43fa0b84-0727-451f-a877-8d689365369e

Fentalis TTS 75 mcg/h 5 Stk

Fentalis TTS 75 mcg/h 10 Stk

Marketing Authorisation 67800009-51476667-915a-4ae9-bf96-c2e7435aca42 for PackagedProductDefinition 51476667-915a-4ae9-bf96-c2e7435aca42

Marketing Authorisation 67800010-4f40bc83-b09c-44ad-bb90-c41b02d626a1 for PackagedProductDefinition 4f40bc83-b09c-44ad-bb90-c41b02d626a1

Reimbursement SL af041f17-52df-41e6-9b97-4b437c3ccedc for PackagedProductDefinition 51476667-915a-4ae9-bf96-c2e7435aca42

Reimbursement SL fd6f60a7-de59-4d67-8661-54dbfe775418 for PackagedProductDefinition 4f40bc83-b09c-44ad-bb90-c41b02d626a1

Fentanylum


Marketing Authorisation 67800 for MedicinalProductDefinition 750ce55a-1ced-4a4d-82c9-1bdeb1844056

Fentalis TTS 100 mcg/h 5 Stk

Fentalis TTS 100 mcg/h 10 Stk

Marketing Authorisation 67800011-1af74b3e-0b67-4ec9-937c-82c523bcafa8 for PackagedProductDefinition 1af74b3e-0b67-4ec9-937c-82c523bcafa8

Marketing Authorisation 67800012-91d46c96-5e1b-4bff-a3f5-edc037558d86 for PackagedProductDefinition 91d46c96-5e1b-4bff-a3f5-edc037558d86

Reimbursement SL 486cd83a-d4e7-4712-affc-0adbc3acac5f for PackagedProductDefinition 1af74b3e-0b67-4ec9-937c-82c523bcafa8

Reimbursement SL 0a7af61d-aafa-4cce-a507-f6f730688608 for PackagedProductDefinition 91d46c96-5e1b-4bff-a3f5-edc037558d86

Fentanylum


Marketing Authorisation 57362 for MedicinalProductDefinition 30ab1523-8fac-484a-a0cf-b127a8eaed79

Fentanyl-Mepha Matrixpfl 12 mcg/h 5 Stk

Fentanyl-Mepha Matrixpfl 12 mcg/h 10 Stk

Marketing Authorisation 57362016-00b8eed8-e682-464d-9b5f-5eb136f0a02e for PackagedProductDefinition 00b8eed8-e682-464d-9b5f-5eb136f0a02e

Marketing Authorisation 57362010-1322fbd6-2c77-4885-ba5c-e3ac9d19da8a for PackagedProductDefinition 1322fbd6-2c77-4885-ba5c-e3ac9d19da8a

Reimbursement SL 0240d0b8-c621-47d6-b738-92d0d6d9c30e for PackagedProductDefinition 00b8eed8-e682-464d-9b5f-5eb136f0a02e

Reimbursement SL 1a6ac7d7-17e4-47d1-85be-31ce04f5f2db for PackagedProductDefinition 1322fbd6-2c77-4885-ba5c-e3ac9d19da8a

Fentanylum


Marketing Authorisation 57362 for MedicinalProductDefinition 55e0c017-43ef-4e68-abcb-2b84c113d64f

Fentanyl-Mepha Matrixpfl 25 mcg/h 5 Stk

Fentanyl-Mepha Matrixpfl 25 mcg/h 10 Stk

Marketing Authorisation 57362009-2b5e2954-ea8b-4230-b594-96eac3749604 for PackagedProductDefinition 2b5e2954-ea8b-4230-b594-96eac3749604

Marketing Authorisation 57362002-e7349f93-a21b-449f-864e-7ce691b6df7b for PackagedProductDefinition e7349f93-a21b-449f-864e-7ce691b6df7b

Reimbursement SL 06de5211-db57-49c1-b6e8-09eea20c4301 for PackagedProductDefinition 2b5e2954-ea8b-4230-b594-96eac3749604

Reimbursement SL a8de4682-64b1-42e7-a176-28f79adea7bf for PackagedProductDefinition e7349f93-a21b-449f-864e-7ce691b6df7b

Fentanylum


Marketing Authorisation 57362 for MedicinalProductDefinition 0d876917-ea09-46ba-b709-c4db9e49221d

Fentanyl-Mepha Matrixpfl 50 mcg/h 5 Stk

Fentanyl-Mepha Matrixpfl 50 mcg/h 10 Stk

Marketing Authorisation 57362011-c76a1290-303c-412b-9655-14bf39e228b0 for PackagedProductDefinition c76a1290-303c-412b-9655-14bf39e228b0

Marketing Authorisation 57362004-091243eb-2414-4c1a-b1ed-32535914af75 for PackagedProductDefinition 091243eb-2414-4c1a-b1ed-32535914af75

Reimbursement SL b01577aa-7195-4dba-b5cf-bf38418ab649 for PackagedProductDefinition c76a1290-303c-412b-9655-14bf39e228b0

Reimbursement SL 55f4ed30-179c-43dd-ab36-b6435f28c4de for PackagedProductDefinition 091243eb-2414-4c1a-b1ed-32535914af75

Fentanylum


Marketing Authorisation 57362 for MedicinalProductDefinition b915ee02-aee2-4b9a-b7ec-6ddfc273a314

Fentanyl-Mepha Matrixpfl 75 mcg/h 5 Stk

Fentanyl-Mepha Matrixpfl 75 mcg/h 10 Stk

Marketing Authorisation 57362013-b589f5f1-5091-4555-b8d2-a4fb45f9a6d1 for PackagedProductDefinition b589f5f1-5091-4555-b8d2-a4fb45f9a6d1

Marketing Authorisation 57362006-a885fe34-eedc-4a48-a644-bdc6200e30c8 for PackagedProductDefinition a885fe34-eedc-4a48-a644-bdc6200e30c8

Reimbursement SL 55cfe8a1-fa5e-4c98-9651-10198974729b for PackagedProductDefinition b589f5f1-5091-4555-b8d2-a4fb45f9a6d1

Reimbursement SL b0cc6601-06a9-4915-a6cc-23fa4742f004 for PackagedProductDefinition a885fe34-eedc-4a48-a644-bdc6200e30c8

Fentanylum


Marketing Authorisation 57362 for MedicinalProductDefinition 4ce4bff0-68bd-4b79-886a-25cfe8e8878d

Fentanyl-Mepha Matrixpfl 100 mcg/h 5 Stk

Fentanyl-Mepha Matrixpfl 100 mcg/h 10 Stk

Marketing Authorisation 57362015-7da26a82-2b14-48cd-9818-0839a90610ec for PackagedProductDefinition 7da26a82-2b14-48cd-9818-0839a90610ec

Marketing Authorisation 57362008-cc2b2ce6-58f2-4767-8867-4ecc85984255 for PackagedProductDefinition cc2b2ce6-58f2-4767-8867-4ecc85984255

Reimbursement SL 7a68dee7-05a4-4875-b745-0c1c36ac9cf0 for PackagedProductDefinition 7da26a82-2b14-48cd-9818-0839a90610ec

Reimbursement SL ad6040f5-49a1-46a8-8c15-6834ce5c3ff9 for PackagedProductDefinition cc2b2ce6-58f2-4767-8867-4ecc85984255

Fentanylum


Marketing Authorisation 59132 for MedicinalProductDefinition f225c7ba-fd3d-43f1-b2ac-e82ca14145d2

Fentanyl Spirig HC Matrixpfl 12 mcg/h 5 Stk

Fentanyl Spirig HC Matrixpfl 12 mcg/h 10 Stk

Marketing Authorisation 59132011-8bf14eae-a7e5-4daf-8b9a-9320af898356 for PackagedProductDefinition 8bf14eae-a7e5-4daf-8b9a-9320af898356

Marketing Authorisation 59132012-821c1e8b-0cf8-4cad-a35b-8ca26a43fdb0 for PackagedProductDefinition 821c1e8b-0cf8-4cad-a35b-8ca26a43fdb0

Reimbursement SL f8c5e23d-9c5b-4f34-8338-9333b4aa100f for PackagedProductDefinition 8bf14eae-a7e5-4daf-8b9a-9320af898356

Reimbursement SL 3a8b5f35-42da-4153-9345-326d0c98a86b for PackagedProductDefinition 821c1e8b-0cf8-4cad-a35b-8ca26a43fdb0

Fentanylum


Marketing Authorisation 59132 for MedicinalProductDefinition 44999412-9ea2-4b0b-b408-d5c29c5d884a

Fentanyl Spirig HC Matrixpfl 25 mcg/h 5 Stk

Fentanyl Spirig HC Matrixpfl 25 mcg/h 10 Stk

Marketing Authorisation 59132013-41093836-19ce-4c79-9446-ab592db2401b for PackagedProductDefinition 41093836-19ce-4c79-9446-ab592db2401b

Marketing Authorisation 59132014-87dfff7d-f9a3-4fd1-9981-f7e921baa93a for PackagedProductDefinition 87dfff7d-f9a3-4fd1-9981-f7e921baa93a

Reimbursement SL 10f98b4d-daf2-4252-96c0-e99f44ec13cc for PackagedProductDefinition 41093836-19ce-4c79-9446-ab592db2401b

Reimbursement SL 9f67321f-60aa-4b35-b892-461475f7b2d6 for PackagedProductDefinition 87dfff7d-f9a3-4fd1-9981-f7e921baa93a

Fentanylum


Marketing Authorisation 59132 for MedicinalProductDefinition 8cf812f4-5e17-473a-9615-3df5ca31869f

Fentanyl Spirig HC Matrixpfl 50 mcg/h 5 Stk

Fentanyl Spirig HC Matrixpfl 50 mcg/h 10 Stk

Marketing Authorisation 59132015-6b1e814c-c9ad-4181-bd68-6c36725931c5 for PackagedProductDefinition 6b1e814c-c9ad-4181-bd68-6c36725931c5

Marketing Authorisation 59132016-bbf45c4c-1005-46b4-bc76-e6df44818264 for PackagedProductDefinition bbf45c4c-1005-46b4-bc76-e6df44818264

Reimbursement SL 85eeae8f-a1d1-47ff-a651-3d1fe595455a for PackagedProductDefinition 6b1e814c-c9ad-4181-bd68-6c36725931c5

Reimbursement SL 4043a657-fd0d-4436-8368-2533f8016159 for PackagedProductDefinition bbf45c4c-1005-46b4-bc76-e6df44818264

Fentanylum


Marketing Authorisation 59132 for MedicinalProductDefinition e60b46bb-4568-4a61-9888-f4979543e07b

Fentanyl Spirig HC Matrixpfl 75 mcg/h 5 Stk

Fentanyl Spirig HC Matrixpfl 75 mcg/h 10 Stk

Marketing Authorisation 59132017-4d13bd0d-53aa-4aaf-95a0-1a61be3ae308 for PackagedProductDefinition 4d13bd0d-53aa-4aaf-95a0-1a61be3ae308

Marketing Authorisation 59132018-d7108b19-dd40-4713-adb5-345354bf205b for PackagedProductDefinition d7108b19-dd40-4713-adb5-345354bf205b

Reimbursement SL c06c88f8-4c46-4b85-9a47-921694e3a7ce for PackagedProductDefinition 4d13bd0d-53aa-4aaf-95a0-1a61be3ae308

Reimbursement SL 046b6deb-7a24-4b52-9d12-3a34733c32ad for PackagedProductDefinition d7108b19-dd40-4713-adb5-345354bf205b

Fentanylum


Marketing Authorisation 59132 for MedicinalProductDefinition e4418320-38ee-4313-8177-abd006105446

Fentanyl Spirig HC Matrixpfl 100 mcg/h 5 Stk

Fentanyl Spirig HC Matrixpfl 100 mcg/h 10 Stk

Marketing Authorisation 59132019-83ed3439-a456-4925-a1cf-51a2285e6e63 for PackagedProductDefinition 83ed3439-a456-4925-a1cf-51a2285e6e63

Marketing Authorisation 59132020-b7eaf951-fcba-40d8-955e-8e23b3d78c04 for PackagedProductDefinition b7eaf951-fcba-40d8-955e-8e23b3d78c04

Reimbursement SL 5caa14f7-e2de-4d9d-88b9-02f5fa7a8bde for PackagedProductDefinition 83ed3439-a456-4925-a1cf-51a2285e6e63

Reimbursement SL 03b552c4-4021-4de4-844c-7983f9923e33 for PackagedProductDefinition b7eaf951-fcba-40d8-955e-8e23b3d78c04

Fentanylum


Fentanyl Zentiva TTS patchs mat 12 mcg/h

Marketing Authorisation 58341 for MedicinalProductDefinition a1ce2fe6-cfc9-4e64-8f05-fe6a164cafde

Fentanyl Zentiva TTS Matrixpfl 12 mcg/h 5 Stk

Marketing Authorisation 58341015-b308e92a-7e05-46d0-af9c-6d0307e0369a for PackagedProductDefinition b308e92a-7e05-46d0-af9c-6d0307e0369a

Reimbursement SL cd625cf6-71e0-46d2-824f-a8f521e25bdb for PackagedProductDefinition b308e92a-7e05-46d0-af9c-6d0307e0369a

Fentanylum


Fentanyl Zentiva TTS patchs mat 25 mcg/h

Marketing Authorisation 58341 for MedicinalProductDefinition c85f1a66-3533-4989-a553-545375b7de7a

Fentanyl Zentiva TTS Matrixpfl 25 mcg/h 5 Stk

Marketing Authorisation 58341001-2b4b8785-51c6-436a-93d1-2a7ee79dbf3b for PackagedProductDefinition 2b4b8785-51c6-436a-93d1-2a7ee79dbf3b

Reimbursement SL 09297f81-e858-4337-9622-dccea083e6a8 for PackagedProductDefinition 2b4b8785-51c6-436a-93d1-2a7ee79dbf3b

Fentanylum


Fentanyl Zentiva TTS patchs mat 50 mcg/h

Marketing Authorisation 58341 for MedicinalProductDefinition 9cf65507-23e2-4b0d-9dc1-2844ece699ec

Fentanyl Zentiva TTS Matrixpfl 50 mcg/h 5 Stk

Marketing Authorisation 58341003-29025207-3a36-4dda-b3e0-a2259e5615f5 for PackagedProductDefinition 29025207-3a36-4dda-b3e0-a2259e5615f5

Reimbursement SL 4d543dcb-fdee-4cc8-b254-8f0ed57f6e94 for PackagedProductDefinition 29025207-3a36-4dda-b3e0-a2259e5615f5

Fentanylum


Fentanyl Zentiva TTS patchs mat 75 mcg/h

Marketing Authorisation 58341 for MedicinalProductDefinition 191c4e13-1bb4-4678-a623-f9f8b3cfee37

Fentanyl Zentiva TTS Matrixpfl 75 mcg/h 5 Stk

Marketing Authorisation 58341005-846c5300-9c13-4b62-9ac5-4b4ffeadd3c1 for PackagedProductDefinition 846c5300-9c13-4b62-9ac5-4b4ffeadd3c1

Reimbursement SL 6bb78319-217a-4bd9-b4ee-74d0275de8cf for PackagedProductDefinition 846c5300-9c13-4b62-9ac5-4b4ffeadd3c1

Fentanylum


Fentanyl Zentiva TTS patchs mat 100 mcg/h

Marketing Authorisation 58341 for MedicinalProductDefinition 8a773181-891d-417d-93e9-76540084dc98

Fentanyl Zentiva TTS Matrixpfl 100 mcg/h 5 Stk

Marketing Authorisation 58341007-5c364929-3940-43a2-b64a-00fb02a11ccc for PackagedProductDefinition 5c364929-3940-43a2-b64a-00fb02a11ccc

Reimbursement SL de345563-9102-4e4d-ba55-2b2afdc3d9e6 for PackagedProductDefinition 5c364929-3940-43a2-b64a-00fb02a11ccc

Fentanylum


Marketing Authorisation 57851 for MedicinalProductDefinition 44994f7d-974e-4e88-9f11-cb583a4a1624

Ferinject Inj Lös 100 mg/2ml 5 Durchstf 2 ml

Marketing Authorisation 57851001-1c958c27-142b-4fbe-9b17-d15b401b0696 for PackagedProductDefinition 1c958c27-142b-4fbe-9b17-d15b401b0696

Reimbursement SL 722f63d4-c3ed-40d0-8094-46ac1453a6b8 for PackagedProductDefinition 1c958c27-142b-4fbe-9b17-d15b401b0696

Ferrum(III) ionisatum


Marketing Authorisation 57851 for MedicinalProductDefinition 363fd17a-b9f9-45e6-814d-b2ff425eb3ea

Ferinject Inj Lös 500 mg/10ml Durchstf 10 ml

Ferinject Inj Lös 500 mg/10ml 5 Durchstf 10 ml

Marketing Authorisation 57851004-7e3e379b-658d-4f7c-b83d-a8a95d0edf4e for PackagedProductDefinition 7e3e379b-658d-4f7c-b83d-a8a95d0edf4e

Marketing Authorisation 57851002-fcf60c2b-058f-4a8a-8e1f-9edf79b859c1 for PackagedProductDefinition fcf60c2b-058f-4a8a-8e1f-9edf79b859c1

Reimbursement SL 7b0d28fb-8253-4f2f-961b-6fb11eb7bff3 for PackagedProductDefinition 7e3e379b-658d-4f7c-b83d-a8a95d0edf4e

Reimbursement SL e3bce8c8-4c3f-4aea-b4a5-6dbd98939f57 for PackagedProductDefinition fcf60c2b-058f-4a8a-8e1f-9edf79b859c1

Ferrum(III) ionisatum


Marketing Authorisation 57851 for MedicinalProductDefinition b7fc49ac-d965-40d3-8a6d-4ec7ae6d3ab6

Ferinject Inj Lös 1000 mg/20ml Durchstf 20 ml

Marketing Authorisation 57851005-2c5a819f-d83a-45ca-b53e-7203e997f613 for PackagedProductDefinition 2c5a819f-d83a-45ca-b53e-7203e997f613

Reimbursement SL f2b987dd-5f54-481a-8c99-2a5420f2b673 for PackagedProductDefinition 2c5a819f-d83a-45ca-b53e-7203e997f613

Ferrum(III) ionisatum


Marketing Authorisation 68220 for MedicinalProductDefinition 450cf07b-a813-47ec-9fd4-344be89b744b

FerMed Inj Inf Präp 100 mg/5 ml 5 Amp 5 ml

Marketing Authorisation 68220001-7952b403-ab4b-4f05-bda4-3305f1b288db for PackagedProductDefinition 7952b403-ab4b-4f05-bda4-3305f1b288db

Reimbursement SL 013c5c40-851f-4b41-8808-57adf1e4f350 for PackagedProductDefinition 7952b403-ab4b-4f05-bda4-3305f1b288db

Ferrum(III) ionisatum


Marketing Authorisation 55679 for MedicinalProductDefinition df99bc23-9503-4e57-b36b-bf2389d83507

Ferriprox Filmtabl 500 mg 100 Stk

Marketing Authorisation 55679002-8ffa39c7-9a7b-4133-b9b4-a3b938712697 for PackagedProductDefinition 8ffa39c7-9a7b-4133-b9b4-a3b938712697

Reimbursement SL 001e1457-e542-47cb-a0a1-34242953a04b for PackagedProductDefinition 8ffa39c7-9a7b-4133-b9b4-a3b938712697

Deferipronum

Behandlung von Eisenüberladung bei Patienten mit Thalassaemia major, bei denen eine Behandlung mit Deferoxamin kontraindiziert ist oder bei denen unter Deferoxamin eine schwere Toxizität auftrat.


Marketing Authorisation 36527 for MedicinalProductDefinition f79af812-083a-4dc6-b1ac-a2f24cf6dd51

Ferro Sanol Kaps 100 mg 50 Stk

Marketing Authorisation 36527021-0cf4e195-3252-46a4-8d75-1400ed84da88 for PackagedProductDefinition 0cf4e195-3252-46a4-8d75-1400ed84da88

Reimbursement SL 631a32e2-a6e0-44ef-a49a-dfc1ad5522b9 for PackagedProductDefinition 0cf4e195-3252-46a4-8d75-1400ed84da88

Ferrum(II) ionisatum


Marketing Authorisation 35102 for MedicinalProductDefinition e0719191-b06b-4b5e-9d5b-8a01cce9ca00

Ferrum Hausmann Kaps 100 mg 30 Stk

Ferrum Hausmann Kaps 100 mg 100 Stk

Marketing Authorisation 35102043-2b1396c5-a63c-4583-8ef3-ba1952a49570 for PackagedProductDefinition 2b1396c5-a63c-4583-8ef3-ba1952a49570

Marketing Authorisation 35102051-e74bedc3-8597-493c-bcd5-dfaab263567d for PackagedProductDefinition e74bedc3-8597-493c-bcd5-dfaab263567d

Reimbursement SL 66bf59a8-4fd0-44ab-8faa-90dfb3d70928 for PackagedProductDefinition 2b1396c5-a63c-4583-8ef3-ba1952a49570

Reimbursement SL a24e764d-5214-404e-91c0-9687640d168f for PackagedProductDefinition e74bedc3-8597-493c-bcd5-dfaab263567d

Ferrum(II) ionisatum


Ferrum-Mepha Inject prép inj perf 100 mg/2ml

Marketing Authorisation 68493 for MedicinalProductDefinition d94ad407-3609-42f5-b381-c09ba62129e4

Ferrum-Mepha Inject Inj Inf Präp 100 mg/2ml 5 Durchstf 2 ml

Marketing Authorisation 68493001-ece7a5e3-b053-4df6-8823-d65f00cf267b for PackagedProductDefinition ece7a5e3-b053-4df6-8823-d65f00cf267b

Reimbursement SL d28cfbe4-fd74-4eef-8342-b1c95d25f5f9 for PackagedProductDefinition ece7a5e3-b053-4df6-8823-d65f00cf267b

Ferrum(III) ionisatum


Ferrum-Mepha Inject prép inj perf 500 mg/10ml

Marketing Authorisation 68493 for MedicinalProductDefinition 99f94063-4556-4776-b19c-8ac8c384e56b

Ferrum-Mepha Inject Inj Inf Präp 500 mg/10ml Durchstf 10 ml

Ferrum-Mepha Inject Inj Inf Präp 500 mg/10ml 5 Durchstf 10 ml

Marketing Authorisation 68493003-f6f54e24-83cf-4c8e-8e90-f53001b5dfb0 for PackagedProductDefinition f6f54e24-83cf-4c8e-8e90-f53001b5dfb0

Reimbursement SL b5feec52-2648-47ab-828a-4bad582730c9 for PackagedProductDefinition 246bc1f1-2556-492d-9277-954b5092f71e

Reimbursement SL ca9f2839-a201-41b0-a902-01a4e4c17299 for PackagedProductDefinition f6f54e24-83cf-4c8e-8e90-f53001b5dfb0

Ferrum(III) ionisatum


Ferrum-Mepha Inject prép inj perf 1000 mg/20ml

Marketing Authorisation 68493 for MedicinalProductDefinition 55e20cf5-8be1-4a15-81cf-ceaab026e4f7

Ferrum-Mepha Inject Inj Inf Präp 1000 mg/20ml Durchstf 20 ml

Marketing Authorisation 68493004-9625af5b-a275-47cf-88d1-bd741bc11689 for PackagedProductDefinition 9625af5b-a275-47cf-88d1-bd741bc11689

Reimbursement SL 751b2301-e69e-4137-bd7d-fbaed8a284bc for PackagedProductDefinition 9625af5b-a275-47cf-88d1-bd741bc11689

Ferrum(III) ionisatum


Folsäure (Calcium folinat siehe V03AF03)

Marketing Authorisation 58121 for MedicinalProductDefinition 4686bf2a-81a6-4315-8c73-cc7f0afcfd90

Fertifol Tabl 0.4 mg 28 Stk

Fertifol Tabl 0.4 mg 84 Stk

Marketing Authorisation 58121001-ddc87288-1d57-4289-9b84-6d3725ecc75d for PackagedProductDefinition ddc87288-1d57-4289-9b84-6d3725ecc75d

Marketing Authorisation 58121002-c28e21cf-4f49-403a-903b-3fc9135f4929 for PackagedProductDefinition c28e21cf-4f49-403a-903b-3fc9135f4929

Reimbursement SL 0cbbb28a-12ab-47d8-9809-4bed94c15dbd for PackagedProductDefinition ddc87288-1d57-4289-9b84-6d3725ecc75d

Reimbursement SL f908bd0c-8839-474b-8d2b-6ad178b4aa44 for PackagedProductDefinition c28e21cf-4f49-403a-903b-3fc9135f4929

Acidum folicum


Marketing Authorisation 69412 for MedicinalProductDefinition 2be42efb-5f39-414b-bdad-ba4f0e484efa

Feryxa Inj Inf Präp 100 mg/2ml 5 Durchstf 2 ml

Marketing Authorisation 69412001-32bff3fa-b7e6-4e9f-b291-7bd840f00b55 for PackagedProductDefinition 32bff3fa-b7e6-4e9f-b291-7bd840f00b55

Reimbursement SL 07740552-e99b-4c1b-9c7d-2d24f4fd94d2 for PackagedProductDefinition 32bff3fa-b7e6-4e9f-b291-7bd840f00b55

Ferrum(III) ionisatum


Marketing Authorisation 69412 for MedicinalProductDefinition 011745b4-6898-47e0-bd7c-4c9ed03b514b

Feryxa Inj Inf Präp 500 mg/10ml Durchstf 10 ml

Feryxa Inj Inf Präp 500 mg/10ml 5 Durchstf 10 ml

Marketing Authorisation 69412004-c71e2d8a-d61b-4b7b-a80a-df6b87869f56 for PackagedProductDefinition c71e2d8a-d61b-4b7b-a80a-df6b87869f56

Marketing Authorisation 69412003-23e77b4b-07b9-42bd-8899-6c5013d453b0 for PackagedProductDefinition 23e77b4b-07b9-42bd-8899-6c5013d453b0

Reimbursement SL 07c2ee86-d7d9-4869-aac6-a992714460a0 for PackagedProductDefinition c71e2d8a-d61b-4b7b-a80a-df6b87869f56

Reimbursement SL 37b30483-91d3-4193-a375-71e8c3ebbacf for PackagedProductDefinition 23e77b4b-07b9-42bd-8899-6c5013d453b0

Ferrum(III) ionisatum


Marketing Authorisation 69412 for MedicinalProductDefinition 3bc3bb8e-2085-4b35-ad06-4d61fa89e0ef

Feryxa Inj Inf Präp 1000 mg/20ml Durchstf 20 ml

Marketing Authorisation 69412005-a0c0dbae-ed26-4aaa-8063-3911cee6cdd8 for PackagedProductDefinition a0c0dbae-ed26-4aaa-8063-3911cee6cdd8

Reimbursement SL cbf4bf46-d2e0-4c4d-ace0-a01ee5927855 for PackagedProductDefinition a0c0dbae-ed26-4aaa-8063-3911cee6cdd8

Ferrum(III) ionisatum


05.02. Mittel gegen Erkrankungen der Harnwege

Marketing Authorisation 68790 for MedicinalProductDefinition 8a203e7e-f742-4097-94df-176aabaf650d

Fesoterodin-Mepha Ret Tabl 4 mg Blist 14 Stk

Fesoterodin-Mepha Ret Tabl 4 mg Blist 84 Stk

Marketing Authorisation 68790001-7903115f-06e5-41b3-83ac-f3374574feda for PackagedProductDefinition 7903115f-06e5-41b3-83ac-f3374574feda

Marketing Authorisation 68790002-c57834ad-b14f-4bec-93f9-a2e61cb5b103 for PackagedProductDefinition c57834ad-b14f-4bec-93f9-a2e61cb5b103

Reimbursement SL 31fea46b-850d-4303-9f3c-ac6e63775f15 for PackagedProductDefinition 7903115f-06e5-41b3-83ac-f3374574feda

Reimbursement SL e0f60d28-3d1b-4f79-aece-a6d6c1ee3c71 for PackagedProductDefinition c57834ad-b14f-4bec-93f9-a2e61cb5b103

Fesoterodini fumaras


Marketing Authorisation 68790 for MedicinalProductDefinition a16310af-497d-4c91-a7bf-aa431eddd3c1

Fesoterodin-Mepha Ret Tabl 8 mg Blist 14 Stk

Fesoterodin-Mepha Ret Tabl 8 mg Blist 84 Stk

Marketing Authorisation 68790003-25842649-417e-453e-bd11-ba00b4572c13 for PackagedProductDefinition 25842649-417e-453e-bd11-ba00b4572c13

Marketing Authorisation 68790004-0ff1754b-6280-4218-8b33-f697e228feb2 for PackagedProductDefinition 0ff1754b-6280-4218-8b33-f697e228feb2

Reimbursement SL ed381c16-7483-4f20-bf0f-6815679c2141 for PackagedProductDefinition 25842649-417e-453e-bd11-ba00b4572c13

Reimbursement SL 4c76d6c0-c3e0-4eef-9982-4987f9d4b5f7 for PackagedProductDefinition 0ff1754b-6280-4218-8b33-f697e228feb2

Fesoterodini fumaras


Marketing Authorisation 69550 for MedicinalProductDefinition a54f8db2-09c4-456c-98df-88e3255c97ed

Fesoterodin Spirig HC Ret Tabl 4 mg Blist 14 Stk

Fesoterodin Spirig HC Ret Tabl 4 mg Blist 84 Stk

Marketing Authorisation 69550001-92b225cd-5be8-4215-9624-b41ff55be930 for PackagedProductDefinition 92b225cd-5be8-4215-9624-b41ff55be930

Marketing Authorisation 69550002-b9f7dd83-d745-44f8-a710-f58216d16d1e for PackagedProductDefinition b9f7dd83-d745-44f8-a710-f58216d16d1e

Reimbursement SL 50935ada-773f-4662-a43f-590fece7481a for PackagedProductDefinition 92b225cd-5be8-4215-9624-b41ff55be930

Reimbursement SL d5789e41-2fe1-4973-8fc0-54278c07a415 for PackagedProductDefinition b9f7dd83-d745-44f8-a710-f58216d16d1e

Fesoterodini fumaras


Marketing Authorisation 69550 for MedicinalProductDefinition b58c6b98-b232-4cb5-94c8-bd1cf3a5970b

Fesoterodin Spirig HC Ret Tabl 8 mg Blist 14 Stk

Fesoterodin Spirig HC Ret Tabl 8 mg Blist 84 Stk

Marketing Authorisation 69550003-5fbe5851-c4a3-43e0-a1dd-1e152c71cba9 for PackagedProductDefinition 5fbe5851-c4a3-43e0-a1dd-1e152c71cba9

Marketing Authorisation 69550004-3ada2f0b-6991-479d-90ee-b6f2584ef80d for PackagedProductDefinition 3ada2f0b-6991-479d-90ee-b6f2584ef80d

Reimbursement SL 692ba03e-4690-44af-a738-691297abfa5a for PackagedProductDefinition 5fbe5851-c4a3-43e0-a1dd-1e152c71cba9

Reimbursement SL ae5c48a5-1d88-4df9-b22f-c29203b7a623 for PackagedProductDefinition 3ada2f0b-6991-479d-90ee-b6f2584ef80d

Fesoterodini fumaras


Marketing Authorisation 68694 for MedicinalProductDefinition 88aa2a59-36d2-4e95-b436-b522866b9989

Fesoterodin Zentiva Ret Tabl 4 mg Blist 14 Stk

Fesoterodin Zentiva Ret Tabl 4 mg Blist 84 Stk

Marketing Authorisation 68694001-71661e67-2c13-436d-8b10-1b77aa0c20eb for PackagedProductDefinition 71661e67-2c13-436d-8b10-1b77aa0c20eb

Marketing Authorisation 68694002-7ca6e917-6b2a-4a99-8c28-3dbc2c3534c3 for PackagedProductDefinition 7ca6e917-6b2a-4a99-8c28-3dbc2c3534c3

Reimbursement SL 8096993f-7e7d-4a26-9f3f-6c1004592b33 for PackagedProductDefinition 71661e67-2c13-436d-8b10-1b77aa0c20eb

Reimbursement SL 66f0f4fe-ffc1-455b-91cc-cab132c796c9 for PackagedProductDefinition 7ca6e917-6b2a-4a99-8c28-3dbc2c3534c3

Fesoterodini fumaras


Marketing Authorisation 68694 for MedicinalProductDefinition 4861b273-a715-4869-b516-868c1d444420

Fesoterodin Zentiva Ret Tabl 8 mg Blist 14 Stk

Fesoterodin Zentiva Ret Tabl 8 mg Blist 84 Stk

Marketing Authorisation 68694003-32ee099f-f97c-45ec-8ad0-3e7cf5c3b105 for PackagedProductDefinition 32ee099f-f97c-45ec-8ad0-3e7cf5c3b105

Marketing Authorisation 68694004-c4907137-aa72-4286-beb4-ca3c495e02c8 for PackagedProductDefinition c4907137-aa72-4286-beb4-ca3c495e02c8

Reimbursement SL c965247f-cb34-4250-aef0-a91e9e20ea65 for PackagedProductDefinition 32ee099f-f97c-45ec-8ad0-3e7cf5c3b105

Reimbursement SL 5758f327-1aa8-4dac-ac6a-fe63b7ee8c7e for PackagedProductDefinition c4907137-aa72-4286-beb4-ca3c495e02c8

Fesoterodini fumaras


Marketing Authorisation 58327 for MedicinalProductDefinition c73042a0-93b4-4ba5-99fc-434d72dcc0a2

Fexofenadine Zentiva Filmtabl 120 mg 10 Stk

Fexofenadine Zentiva Filmtabl 120 mg Blist 30 Stk

Marketing Authorisation 58327020-b4ae7e0f-8261-4627-88c1-fee2597e66b7 for PackagedProductDefinition b4ae7e0f-8261-4627-88c1-fee2597e66b7

Marketing Authorisation 58327003-bab9d659-1547-4085-999c-d348dbfd40c9 for PackagedProductDefinition bab9d659-1547-4085-999c-d348dbfd40c9

Reimbursement SL d5dbbd93-a3a1-41f1-9d82-3db510d4b0b8 for PackagedProductDefinition b4ae7e0f-8261-4627-88c1-fee2597e66b7

Reimbursement SL caf28d0c-ec89-4ed8-9726-292beb120402 for PackagedProductDefinition bab9d659-1547-4085-999c-d348dbfd40c9

Fexofenadini hydrochloridum


Marketing Authorisation 58327 for MedicinalProductDefinition 0de26e7c-da14-421a-8517-ec81b7429f0e

Fexofenadine Zentiva Filmtabl 180 mg Blist 10 Stk

Fexofenadine Zentiva Filmtabl 180 mg Blist 30 Stk

Marketing Authorisation 58327022-3295a0c0-e0e7-4033-84f7-fd471496f8a5 for PackagedProductDefinition 3295a0c0-e0e7-4033-84f7-fd471496f8a5

Reimbursement SL 28ed5f38-42f5-4f56-a0ca-be291d5572ba for PackagedProductDefinition 3295a0c0-e0e7-4033-84f7-fd471496f8a5

Reimbursement SL 98d00182-3cb0-4a0d-bc4b-f79c89cf8dc5 for PackagedProductDefinition 70e10433-d34b-4055-a763-64eda6961620

Fexofenadini hydrochloridum


Marketing Authorisation 67369 for MedicinalProductDefinition 362f43f3-42a7-43c3-aa42-4b54845c56f6

Fexofenadin-Mepha Filmtabl 120 mg Blist 10 Stk

Fexofenadin-Mepha Filmtabl 120 mg Blist 30 Stk

Fexofenadin-Mepha Filmtabl 120 mg Blist 50 Stk

Marketing Authorisation 67369001-028be191-e7ac-4881-b24b-6ec6729ec213 for PackagedProductDefinition 028be191-e7ac-4881-b24b-6ec6729ec213

Marketing Authorisation 67369002-c30b5417-c6f6-45a8-a448-82dbb69d68d7 for PackagedProductDefinition c30b5417-c6f6-45a8-a448-82dbb69d68d7

Marketing Authorisation 67369005-72e86bb6-e819-4b5a-8fc2-084680e0cf38 for PackagedProductDefinition 72e86bb6-e819-4b5a-8fc2-084680e0cf38

Reimbursement SL 288cf3be-b7b0-4821-9016-a0b9c06a0a0d for PackagedProductDefinition 028be191-e7ac-4881-b24b-6ec6729ec213

Reimbursement SL 7133680b-cb59-4f75-b502-309fcc7edfda for PackagedProductDefinition c30b5417-c6f6-45a8-a448-82dbb69d68d7

Reimbursement SL cf982f29-ffb0-4768-9dc7-0066a05f5c79 for PackagedProductDefinition 72e86bb6-e819-4b5a-8fc2-084680e0cf38

Fexofenadini hydrochloridum


Marketing Authorisation 67369 for MedicinalProductDefinition e64f8ba2-2870-4a37-8d10-316da7fca180

Fexofenadin-Mepha Filmtabl 180 mg Blist 10 Stk

Fexofenadin-Mepha Filmtabl 180 mg Blist 30 Stk

Fexofenadin-Mepha Filmtabl 180 mg Blist 50 Stk

Marketing Authorisation 67369003-a29aeffa-efde-4127-8226-b1fca98571da for PackagedProductDefinition a29aeffa-efde-4127-8226-b1fca98571da

Marketing Authorisation 67369004-5e60f43f-40a2-46ef-b7e7-d75511ed8fa0 for PackagedProductDefinition 5e60f43f-40a2-46ef-b7e7-d75511ed8fa0

Reimbursement SL 00dc53b0-53ba-4ec2-8f32-fec3fcbc98d6 for PackagedProductDefinition a29aeffa-efde-4127-8226-b1fca98571da

Reimbursement SL b871280b-8b97-4339-bdc8-954415d27396 for PackagedProductDefinition 5e60f43f-40a2-46ef-b7e7-d75511ed8fa0

Fexofenadini hydrochloridum


Marketing Authorisation 66343 for MedicinalProductDefinition a4cb542e-3cc6-4d31-822e-d190aa61aa8b

Fexofenadin Sandoz Filmtabl 120 mg 10 Stk

Fexofenadin Sandoz Filmtabl 120 mg 30 Stk

Marketing Authorisation 66343001-c38d5eba-a156-46cd-b2fd-c6b3b58f5d33 for PackagedProductDefinition c38d5eba-a156-46cd-b2fd-c6b3b58f5d33

Marketing Authorisation 66343002-76d80faf-b0b9-41fb-894d-1332744cd605 for PackagedProductDefinition 76d80faf-b0b9-41fb-894d-1332744cd605

Reimbursement SL 12a045b0-51ea-4376-8576-c2fd349dfc92 for PackagedProductDefinition c38d5eba-a156-46cd-b2fd-c6b3b58f5d33

Reimbursement SL 594a65fe-b46b-4560-8dfc-23e22942f135 for PackagedProductDefinition 76d80faf-b0b9-41fb-894d-1332744cd605

Fexofenadini hydrochloridum


Marketing Authorisation 66343 for MedicinalProductDefinition ec217bd5-2b13-433f-9d5e-11dd073b9006

Fexofenadin Sandoz Filmtabl 180 mg 10 Stk

Fexofenadin Sandoz Filmtabl 180 mg 30 Stk

Marketing Authorisation 66343003-3668409e-b008-4540-b3ee-252a635af786 for PackagedProductDefinition 3668409e-b008-4540-b3ee-252a635af786

Reimbursement SL 6dd92a1d-7c1a-4256-a294-e657f80cac53 for PackagedProductDefinition 3668409e-b008-4540-b3ee-252a635af786

Reimbursement SL dc72b7bd-c2f5-4745-8ae6-67ccb690e3e2 for PackagedProductDefinition 2c594320-fc70-4b11-8475-376b87b84a72

Fexofenadini hydrochloridum


Marketing Authorisation 68435 for MedicinalProductDefinition 37369cef-7ca8-4087-8a7c-b9d35532623a

Fexofenadin Spirig HC Filmtabl 120 mg 10 Stk

Fexofenadin Spirig HC Filmtabl 120 mg 30 Stk

Fexofenadin Spirig HC Filmtabl 120 mg 70 Stk

Marketing Authorisation 68435001-dda31b0a-bf50-434c-856f-709e358fd91d for PackagedProductDefinition dda31b0a-bf50-434c-856f-709e358fd91d

Marketing Authorisation 68435005-f97c0cb8-0537-45cc-9950-a6d7481ba051 for PackagedProductDefinition f97c0cb8-0537-45cc-9950-a6d7481ba051

Marketing Authorisation 68435008-f0ea69ec-cd45-4bb6-b330-0413ef05b7c6 for PackagedProductDefinition f0ea69ec-cd45-4bb6-b330-0413ef05b7c6

Reimbursement SL 9dc8f2be-9cfd-457a-b05b-5df06c48207b for PackagedProductDefinition dda31b0a-bf50-434c-856f-709e358fd91d

Reimbursement SL 032f5e73-2c1d-423a-a61e-d5ca2ee45b4f for PackagedProductDefinition f97c0cb8-0537-45cc-9950-a6d7481ba051

Reimbursement SL c746fa52-f62b-4f35-b3b7-bd40b7dddbe7 for PackagedProductDefinition f0ea69ec-cd45-4bb6-b330-0413ef05b7c6

Fexofenadini hydrochloridum


Marketing Authorisation 68435 for MedicinalProductDefinition 64312b18-87cf-4d5a-900d-a4634fe5d19f

Fexofenadin Spirig HC Filmtabl 180 mg 10 Stk

Fexofenadin Spirig HC Filmtabl 180 mg 30 Stk

Fexofenadin Spirig HC Filmtabl 180 mg 70 Stk

Marketing Authorisation 68435006-b5c87598-5a83-416a-aebb-b10787817b32 for PackagedProductDefinition b5c87598-5a83-416a-aebb-b10787817b32

Marketing Authorisation 68435007-6c292278-b4ea-4df6-a354-f4ce69b04671 for PackagedProductDefinition 6c292278-b4ea-4df6-a354-f4ce69b04671

Marketing Authorisation 68435009-a318e571-73ca-468f-82a6-60394f2ebfd9 for PackagedProductDefinition a318e571-73ca-468f-82a6-60394f2ebfd9

Reimbursement SL 90cc738b-61a1-4296-a39a-55170911f9cc for PackagedProductDefinition b5c87598-5a83-416a-aebb-b10787817b32

Reimbursement SL f1aff02a-1d85-48d0-ad1a-81627805e944 for PackagedProductDefinition 6c292278-b4ea-4df6-a354-f4ce69b04671

Reimbursement SL 8eb84613-fda6-4bb8-9dc1-ac7d639082b3 for PackagedProductDefinition a318e571-73ca-468f-82a6-60394f2ebfd9

Fexofenadini hydrochloridum


Marketing Authorisation 66202 for MedicinalProductDefinition 02c19b92-1bc1-4256-943e-816b2cc50f7a

Fiasp Inj Lös 100 E/ml Durchstf 10 ml

Marketing Authorisation 66202001-be2a5db5-bd72-404b-aa7a-8ea903548b71 for PackagedProductDefinition be2a5db5-bd72-404b-aa7a-8ea903548b71

Reimbursement SL 7e58b2b0-3f0d-4b35-a528-93465bd28809 for PackagedProductDefinition be2a5db5-bd72-404b-aa7a-8ea903548b71

Insulinum aspartum


Marketing Authorisation 66200 for MedicinalProductDefinition 32305cdf-1672-4964-b0e0-759247eb6556

Fiasp FlexTouch Inj Lös 100 E/ml 5 Fertpen 3 ml

Marketing Authorisation 66200001-0141dc7e-e68f-432e-be26-a7f2c940ed06 for PackagedProductDefinition 0141dc7e-e68f-432e-be26-a7f2c940ed06

Reimbursement SL 30fece02-fec7-4082-9466-287f8ae9b5cf for PackagedProductDefinition 0141dc7e-e68f-432e-be26-a7f2c940ed06

Insulinum aspartum


Fiasp Penfill sol inj 100 U/ml cartouche

Marketing Authorisation 66201 for MedicinalProductDefinition 098fc185-2a06-4366-9e21-2a43a3de9cca

Fiasp Penfill Inj Lös 100 E/ml Patrone 5 Amp 3 ml

Marketing Authorisation 66201001-eeb03bee-c8a1-40e4-82fd-5588ddd088a1 for PackagedProductDefinition eeb03bee-c8a1-40e4-82fd-5588ddd088a1

Reimbursement SL 9dac046d-b047-4790-912f-e3854aab6787 for PackagedProductDefinition eeb03bee-c8a1-40e4-82fd-5588ddd088a1

Insulinum aspartum


Fiasp PumpCart sol inj 100 U/ml cartouche

Marketing Authorisation 67809 for MedicinalProductDefinition 2372dc0d-0151-4a19-818f-9b00597951e6

Fiasp PumpCart Inj Lös 100 E/ml Patrone 5 Amp 1.6 ml

Reimbursement SL 0ac06527-9b83-4293-b34f-614c8e8a1aa3 for PackagedProductDefinition 19663d59-35bb-40f0-92b0-5b508284b244

Insulinum aspartum


06.01.10. Blutkonserven und Plasmafraktionen

Fibrogammin subst sèche 1250 UI c solv disp transf

Marketing Authorisation 671 for MedicinalProductDefinition 1fc0c04a-49e7-4b1f-9ca7-0c9a16bd07c3

Fibrogammin Trockensub 1250 IE c Solv Transfer Set 1 Stk

Marketing Authorisation 671006-0ea50eb4-cf2d-40fd-a59c-0173aa1e0908 for PackagedProductDefinition 0ea50eb4-cf2d-40fd-a59c-0173aa1e0908

Reimbursement SL 205b5ebd-4358-47b7-bea7-6a07aabb0930 for PackagedProductDefinition 0ea50eb4-cf2d-40fd-a59c-0173aa1e0908

Factor XIII coagulationis humanus 1250 UI

Factor XIII coagulationis humanus

Preisberechnung für Blutpräparate aufgrund des Fabrikabgabepreises zuzüglich einer Fixmarge wegen der speziellen Verteilersituation (praktisch kein Zwischenhandel) von Fr. 40.-- zuzüglich MWST. Diese Berechnung gilt nicht für die Humanalbumine.

Bei Faktor XIII-Mangel.


Fibrogammin subst sèche 250 UI c solv disp transf

Marketing Authorisation 671 for MedicinalProductDefinition 6e5becb2-1806-4b8e-8b12-9b7fd183ebbb

Fibrogammin Trockensub 250 IE c Solv Transfer Set 1 Stk

Reimbursement SL 7edad55d-18f5-49b3-a1a2-1c55b3c23195 for PackagedProductDefinition 84563e82-2628-4b13-b34a-c8404338570b

Factor XIII coagulationis humanus 250 UI

Factor XIII coagulationis humanus

Bei Faktor XIII-Mangel.


Human-Fibrinogen - Blutgerinnungsfaktor I

Fibryga subst sèche 1 g c solv (nextaro)

Marketing Authorisation 66836 for MedicinalProductDefinition 7960ffc2-201f-4a3f-bc33-0432fa5a08d7

Fibryga Trockensub 1 g c Solv (nextaro) Durchstf 1 Stk

Marketing Authorisation 66836003-2a17175c-11f3-4631-af45-184adc007a31 for PackagedProductDefinition 2a17175c-11f3-4631-af45-184adc007a31

Reimbursement SL 42255a98-a82c-4560-b9da-237ff8ba555f for PackagedProductDefinition 2a17175c-11f3-4631-af45-184adc007a31

Fibrinogenum humanum


Marketing Authorisation 60722 for MedicinalProductDefinition 1516ed9f-4296-49a4-8a5f-3b3e3a1a136d

Filgrastim-Teva Inj Lös 30 Mio E/0.5ml Fertigspr 0.5 ml

Filgrastim-Teva Inj Lös 30 Mio E/0.5ml 5 Fertigspr 0.5 ml

Marketing Authorisation 60722001-f09a66fa-6996-4f05-87eb-fa62409550e6 for PackagedProductDefinition f09a66fa-6996-4f05-87eb-fa62409550e6

Marketing Authorisation 60722002-9bc074fa-b90b-4129-8622-f87b1afef744 for PackagedProductDefinition 9bc074fa-b90b-4129-8622-f87b1afef744

Reimbursement SL 61226097-d044-441b-91ec-f60991eab4fd for PackagedProductDefinition f09a66fa-6996-4f05-87eb-fa62409550e6

Reimbursement SL 8034f98c-9d26-4614-b3ec-8ad48559d08c for PackagedProductDefinition 9bc074fa-b90b-4129-8622-f87b1afef744

Filgrastimum ADNr

Anwendung bei erfolgversprechenden, stark myelotoxischen Chemotherapien bei Patienten, die wegen eingeschränkter Knochenmarkreserven besonders infektionsgefährdet sind. FILGRASTIM ist indiziert für die Mobilisierung von Vorläuferzellen des peripheren Blutes (PBPC) vor einer Leukapherese, um bei Patienten mit myelosuppressiver Behandlung durch eine Transplantation solcher Zellen die hämatologische Wiederherstellung zu beschleunigen. Schwere kongenitale Neutropenie (Kostman Syndrom), zyklische Neutropenie, chronische idiopathische Neutropenie (Langzeitanwendung zur Erhöhung der neutrophilen Granulozytenzahl Bereich 1000 bis 3000 Granulozyten pro mcl und Reduktion der Infektionen bei Kindern und Erwachsenen mit klinisch signifikanten Infektionen während der vergangenen 12 Monate und dreimalig dokumentierter schwerster Neutropenie (< 0.5 x 10^9 ANC/l) während 6 Monaten und nach Ausschluss von reaktiv bedingten Neutropenien Vitamin B12 Mangel, Autoimmunkrankheiten).


Marketing Authorisation 60722 for MedicinalProductDefinition c4cec84a-2012-4899-816a-675a60ec5867

Filgrastim-Teva Inj Lös 48 Mio E/0.8ml Fertigspr 0.8 ml

Filgrastim-Teva Inj Lös 48 Mio E/0.8ml 5 Fertigspr 0.8 ml

Marketing Authorisation 60722004-e03639c5-ee2d-4413-b527-5c661012e8a4 for PackagedProductDefinition e03639c5-ee2d-4413-b527-5c661012e8a4

Marketing Authorisation 60722005-1651e0d3-e588-4e28-abfd-bb271747560b for PackagedProductDefinition 1651e0d3-e588-4e28-abfd-bb271747560b

Reimbursement SL f0ab1f98-e4fd-45f0-9680-dbf416003329 for PackagedProductDefinition e03639c5-ee2d-4413-b527-5c661012e8a4

Reimbursement SL 95f2dfc6-47d0-4486-b52b-4d9b3fa4bc09 for PackagedProductDefinition 1651e0d3-e588-4e28-abfd-bb271747560b

Filgrastimum ADNr


Marketing Authorisation 58039 for MedicinalProductDefinition 9e2ecd9a-ba85-4737-9a6f-7f80c6e9807f

Finasterax Filmtabl 5 mg 28 Stk

Finasterax Filmtabl 5 mg 98 Stk

Marketing Authorisation 58039001-c8b39d99-5dc0-4c99-860b-27a23251e1c5 for PackagedProductDefinition c8b39d99-5dc0-4c99-860b-27a23251e1c5

Marketing Authorisation 58039002-198c6d9b-5b49-4a0c-99b7-8082f43019ff for PackagedProductDefinition 198c6d9b-5b49-4a0c-99b7-8082f43019ff

Reimbursement SL 0a931fa5-c57d-434d-83e6-ab50470ada51 for PackagedProductDefinition c8b39d99-5dc0-4c99-860b-27a23251e1c5

Reimbursement SL cd8deb27-1fb6-407f-a83f-e05dde91fe45 for PackagedProductDefinition 198c6d9b-5b49-4a0c-99b7-8082f43019ff

Finasteridum


Marketing Authorisation 58107 for MedicinalProductDefinition 41fb7176-7e21-4d46-8ae2-e7fe07f40993

Finasterid-Mepha Lactabs 5 mg 30 Stk

Finasterid-Mepha Lactabs 5 mg 100 Stk

Marketing Authorisation 58107001-23c82b61-6ae1-4eb6-90eb-7d6e2d32cd4c for PackagedProductDefinition 23c82b61-6ae1-4eb6-90eb-7d6e2d32cd4c

Marketing Authorisation 58107002-3e523cab-72e8-465c-9595-9124767ed396 for PackagedProductDefinition 3e523cab-72e8-465c-9595-9124767ed396

Reimbursement SL 9a5b002a-6b56-4d1f-9b4b-d6a0dac59991 for PackagedProductDefinition 23c82b61-6ae1-4eb6-90eb-7d6e2d32cd4c

Reimbursement SL 090ab06f-623c-46d6-9d6a-865b232c3d3e for PackagedProductDefinition 3e523cab-72e8-465c-9595-9124767ed396

Finasteridum


Marketing Authorisation 57890 for MedicinalProductDefinition 08e4dca0-3414-4938-a2f0-fed65a665834

Finasterid Sandoz Filmtabl 5 mg 30 Stk

Finasterid Sandoz Filmtabl 5 mg 100 Stk

Marketing Authorisation 57890001-92b37692-0d88-440b-bb70-89fb748c00ef for PackagedProductDefinition 92b37692-0d88-440b-bb70-89fb748c00ef

Marketing Authorisation 57890002-46b1fabe-40a6-4669-b583-730c1da34aaa for PackagedProductDefinition 46b1fabe-40a6-4669-b583-730c1da34aaa

Reimbursement SL 26565bbd-4fdf-46f2-8982-996b9483808e for PackagedProductDefinition 92b37692-0d88-440b-bb70-89fb748c00ef

Reimbursement SL 4d1f545d-5c3f-41f4-bd67-03401449bcc4 for PackagedProductDefinition 46b1fabe-40a6-4669-b583-730c1da34aaa

Finasteridum


Marketing Authorisation 57979 for MedicinalProductDefinition bbafce5f-e37c-4935-87dd-a31c8d1f6958

Finasterid Spirig HC Filmtabl 5 mg 28 Stk

Finasterid Spirig HC Filmtabl 5 mg 98 Stk

Marketing Authorisation 57979003-1cbf4c8d-8d45-4dc0-b1af-4b3aa5ed7bb0 for PackagedProductDefinition 1cbf4c8d-8d45-4dc0-b1af-4b3aa5ed7bb0

Marketing Authorisation 57979004-edcb9d10-8f1c-43e1-9a6b-67f048bdbc90 for PackagedProductDefinition edcb9d10-8f1c-43e1-9a6b-67f048bdbc90

Reimbursement SL 1a53c51c-20e5-4f92-9426-c7be8fcb04f0 for PackagedProductDefinition 1cbf4c8d-8d45-4dc0-b1af-4b3aa5ed7bb0

Reimbursement SL 2c90668d-18ad-4c5d-8056-0f2c3a1be2f4 for PackagedProductDefinition edcb9d10-8f1c-43e1-9a6b-67f048bdbc90

Finasteridum


Marketing Authorisation 68406 for MedicinalProductDefinition d535e4d6-81fc-4b99-8fa9-3997ce612646

Fingolimod Devatis Kaps 0.5 mg Fl 28 Stk

Fingolimod Devatis Kaps 0.5 mg Fl 98 Stk

Marketing Authorisation 68406004-26bbe81b-c600-4346-9afd-15827c57bb90 for PackagedProductDefinition 26bbe81b-c600-4346-9afd-15827c57bb90

Marketing Authorisation 68406006-1ece8385-542b-404b-a3b6-057aff3acb3a for PackagedProductDefinition 1ece8385-542b-404b-a3b6-057aff3acb3a

Reimbursement SL 4fc1d3e7-8135-4e3a-8377-cdfc78cfbb6e for PackagedProductDefinition 26bbe81b-c600-4346-9afd-15827c57bb90

Reimbursement SL e5f6f2f7-55df-4600-8407-ba1054516ef9 for PackagedProductDefinition 1ece8385-542b-404b-a3b6-057aff3acb3a

Fingolimodum

Behandlung der schubförmig remittierenden multiplen Sklerose (MS) bei Erwachsenen. Erstverschreibung durch den Facharzt für Neurologie.


Marketing Authorisation 68007 for MedicinalProductDefinition cc35cb6a-dada-409b-a0e0-ea81fae60526

Fingolimod-Mepha Kaps 0.5 mg Blist 28 Stk

Fingolimod-Mepha Kaps 0.5 mg Blist 98 Stk

Marketing Authorisation 68007012-248555ea-bdfc-4387-b0bf-64493f3559e9 for PackagedProductDefinition 248555ea-bdfc-4387-b0bf-64493f3559e9

Marketing Authorisation 68007014-105442cd-dc25-45a0-8849-8fa17965b393 for PackagedProductDefinition 105442cd-dc25-45a0-8849-8fa17965b393

Reimbursement SL 5d37f843-5d92-404b-aeac-52d58fcd0f97 for PackagedProductDefinition 248555ea-bdfc-4387-b0bf-64493f3559e9

Reimbursement SL 8d0e7a0a-3dff-41b2-a807-fcdc9066f4df for PackagedProductDefinition 105442cd-dc25-45a0-8849-8fa17965b393

Fingolimodum


Marketing Authorisation 68176 for MedicinalProductDefinition 879cf541-e72d-4e01-83e5-245fd81e93a9

Fingolimod Sandoz Kaps 0.5 mg 28 Stk

Fingolimod Sandoz Kaps 0.5 mg 98 Stk

Marketing Authorisation 68176001-07c597bb-9f8a-4926-adcd-092dabdff77c for PackagedProductDefinition 07c597bb-9f8a-4926-adcd-092dabdff77c

Marketing Authorisation 68176002-ca05f9fb-bc6f-4f1a-8368-be62aa5ce013 for PackagedProductDefinition ca05f9fb-bc6f-4f1a-8368-be62aa5ce013

Reimbursement SL 389c0dbc-e967-4b8f-99ba-f89fc1652ee2 for PackagedProductDefinition 07c597bb-9f8a-4926-adcd-092dabdff77c

Reimbursement SL 20f5ed67-81b0-4030-b509-7ff1d0cedb1d for PackagedProductDefinition ca05f9fb-bc6f-4f1a-8368-be62aa5ce013

Fingolimodum


Marketing Authorisation 67616 for MedicinalProductDefinition 5a19e1df-7a0b-47c6-b303-838dff19bb22

Fingolimod Spirig HC Kaps 0.5 mg Blist 28 Stk

Fingolimod Spirig HC Kaps 0.5 mg Blist 98 Stk

Marketing Authorisation 67616003-78ad9f83-53ea-4abc-8fb2-c9abf5f0cab2 for PackagedProductDefinition 78ad9f83-53ea-4abc-8fb2-c9abf5f0cab2

Marketing Authorisation 67616004-5ad55d68-ce74-4d57-82c4-84b55fd99024 for PackagedProductDefinition 5ad55d68-ce74-4d57-82c4-84b55fd99024

Reimbursement SL 9cda0fa6-52be-4407-bfdb-2e5212c1e8e1 for PackagedProductDefinition 78ad9f83-53ea-4abc-8fb2-c9abf5f0cab2

Reimbursement SL 66ec0d13-49af-4c28-b66e-4eb07f9a8155 for PackagedProductDefinition 5ad55d68-ce74-4d57-82c4-84b55fd99024

Fingolimodum

Behandlung der schubförmig remittierenden multiplen Sklerose (MS) bei Erwachsenen. Erstverschreibung durch den Facharzt für Neurologie.


Marketing Authorisation 68601 for MedicinalProductDefinition 8e9f11be-2e53-400a-96ac-2144d6e7d616

Fingolimod Viatris Kaps 0.5 mg Blist 28 Stk

Fingolimod Viatris Kaps 0.5 mg Blist 98 Stk

Marketing Authorisation 68601001-d1c7f00c-275b-418e-afe1-b7312eaaa66e for PackagedProductDefinition d1c7f00c-275b-418e-afe1-b7312eaaa66e

Marketing Authorisation 68601002-b9801932-a6b3-431d-b2da-6760d7111aa7 for PackagedProductDefinition b9801932-a6b3-431d-b2da-6760d7111aa7

Reimbursement SL 7837bd78-c2f5-4dee-ae19-1ae4399ffa10 for PackagedProductDefinition d1c7f00c-275b-418e-afe1-b7312eaaa66e

Reimbursement SL 6d88eba2-9814-474e-b7b6-c7aa0fe0790a for PackagedProductDefinition b9801932-a6b3-431d-b2da-6760d7111aa7

Fingolimodum


Marketing Authorisation 58178 for MedicinalProductDefinition 3347ec7d-434d-462b-9bd2-ef533e00e0a0

Firazyr Inj Lös 30 mg/3ml Fertigspr 3 ml

Marketing Authorisation 58178001-57940513-d31c-4a91-9903-4d76d19b40ad for PackagedProductDefinition 57940513-d31c-4a91-9903-4d76d19b40ad

Reimbursement SL 32af8f5c-2fd1-4e2a-8092-bb8d2c9527d8 for PackagedProductDefinition 57940513-d31c-4a91-9903-4d76d19b40ad

Icatibantum

Symptomatische Behandlung akuter Attacken eines hereditären Angioödems (HAE) bei Erwachsenen, Jugendlichen und Kindern ab 2 Jahren mit C1-Esterase-Inhibitor-Mangel.


Marketing Authorisation 61853 for MedicinalProductDefinition 0ad41bca-5c80-46d7-ae7b-df34aa5da6c1

Firdapse Tabl 10 mg 100 Stk

Marketing Authorisation 61853001-8931b9f5-0cea-4105-8ddd-a96c47551747 for PackagedProductDefinition 8931b9f5-0cea-4105-8ddd-a96c47551747

Reimbursement SL 747aeebb-c188-4b9f-bf8e-88f50e7fc70c for PackagedProductDefinition 8931b9f5-0cea-4105-8ddd-a96c47551747

Amifampridinum

Die Behandlung mit FIRDAPSE bedarf der Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes. Symptomatische Behandlung des Lambert-Eaton-Myasthenie Syndroms (LEMS) bei Erwachsenen. FIRAPSE darf nur in Spital-basierten, spezialisierten neuromuskulären Zentren des Netzwerks Myosuisse https://myosuisse.org/ueber-uns/nationale-referenzzentren/ von einem Facharzt der Neurologie verschrieben werden. In den sieben Zentren müssen alle LEMS-Patienten erfasst werden, welche mit FIRDAPSE therapiert werden. Die folgenden Angaben sind zu dokumentieren: - Anzahl behandelter Patienten pro Kalenderjahr - Therapiestart, Therapieende / pro Patient - Bei Therapieabbruch: Begründung, weshalb die Therapie abgebrochen wurde Der Therapieerfolg mit FIRDAPSE muss 12 Wochen nach Beginn der Behandlung überprüft werden. Die Therapie mit FIRDAPSE muss abgesetzt werden, wenn keine Wirkung feststellbar.


Firmagon subst sèche 80 mg av ser prê av solv

Marketing Authorisation 59455 for MedicinalProductDefinition 3e4c14db-3b05-4743-908c-ad4826f46f73

Firmagon Trockensub 80 mg mit Solv in Fertspr Set 1 Stk

Marketing Authorisation 59455003-97ed86cb-d89c-4621-ba59-8c347af431dd for PackagedProductDefinition 97ed86cb-d89c-4621-ba59-8c347af431dd

Reimbursement SL 5afe1b70-6747-4cf6-8678-ff5273ff7367 for PackagedProductDefinition 97ed86cb-d89c-4621-ba59-8c347af431dd

Degarelixum


Firmagon subst sèche 120 mg av ser prê av solv

Marketing Authorisation 59455 for MedicinalProductDefinition d6ebaa34-9e23-4928-b6c3-8ac044d2d046

Firmagon Trockensub 120 mg mit Solv in Fertspr Set 2 Stk

Marketing Authorisation 59455004-a3992094-51ff-4f38-96bb-c745842a85bf for PackagedProductDefinition a3992094-51ff-4f38-96bb-c745842a85bf

Reimbursement SL 5128d1d7-5f02-4696-b24d-26bc18ed0b89 for PackagedProductDefinition a3992094-51ff-4f38-96bb-c745842a85bf

Degarelixum


Marketing Authorisation 67295 for MedicinalProductDefinition b15dbd2e-df00-4bd7-b8ac-9c413164aafe

Fixaprost Gtt Opht (Monodosen) 30 Monodos 0.2 ml

Fixaprost Gtt Opht (Monodosen) 90 Monodos 0.2 ml

Reimbursement SL 5b937010-13df-4698-a21d-a2005bb3ad39 for PackagedProductDefinition 01282845-c40e-4053-a5c1-59896f0ef450

Latanoprostum

Timololum


Marketing Authorisation 26313 for MedicinalProductDefinition c63c3779-6880-4519-9f8c-d97c27742704

Flagyl Filmtabl 250 mg 20 Stk

Marketing Authorisation 26313015-d9b17367-0ed0-4987-ad9c-becf396e4355 for PackagedProductDefinition d9b17367-0ed0-4987-ad9c-becf396e4355

Reimbursement SL 096a1684-f71e-4431-89a6-33abd7065ed3 for PackagedProductDefinition d9b17367-0ed0-4987-ad9c-becf396e4355

Metronidazolum


Marketing Authorisation 26313 for MedicinalProductDefinition 5c4e2962-4498-47b0-873e-4d36b7879eed

Flagyl Filmtabl 500 mg 20 Stk

Marketing Authorisation 26313023-9032c204-3f1f-4131-8e3a-5750c4745f4c for PackagedProductDefinition 9032c204-3f1f-4131-8e3a-5750c4745f4c

Reimbursement SL 057607db-66b9-4dae-97b6-7cf888fc2b44 for PackagedProductDefinition 9032c204-3f1f-4131-8e3a-5750c4745f4c

Metronidazolum


Marketing Authorisation 26314 for MedicinalProductDefinition 3052e055-7ec3-4bc1-91e8-c0233019333f

Flagyl Ovula 500 mg 10 Stk

Marketing Authorisation 26314001-3e9afeeb-2d18-4704-8d43-4e3e8c754796 for PackagedProductDefinition 3e9afeeb-2d18-4704-8d43-4e3e8c754796

Reimbursement SL 88428964-5abc-413e-83e8-29608441f1ff for PackagedProductDefinition 3e9afeeb-2d18-4704-8d43-4e3e8c754796

Metronidazolum


Marketing Authorisation 26313 for MedicinalProductDefinition a747c411-ec44-440b-a229-37e2a9d3f557

Flagyl Trichopak Filmtabl 500 mg 4 Stk

Marketing Authorisation 26313031-3cecf68c-7b32-4bff-8b5d-8294a19d7a61 for PackagedProductDefinition 3cecf68c-7b32-4bff-8b5d-8294a19d7a61

Reimbursement SL a60f98d4-035e-4a82-a3af-d9e9b952aa24 for PackagedProductDefinition 3cecf68c-7b32-4bff-8b5d-8294a19d7a61

Metronidazolum


10.09.20. Mittel gegen bakterielle Erreger

Marketing Authorisation 38607 for MedicinalProductDefinition 00a01ef2-88e3-42d2-ac88-6988b5ed30ff

Alliance Pharmaceuticals GmbH, Düsseldorf, Zweigniederlassung

Flammazine Creme 50 g

Flammazine Creme Topf 500 g

Marketing Authorisation 38607014-259e5e33-5cbb-47af-9c1a-4c07e45e9e7c for PackagedProductDefinition 259e5e33-5cbb-47af-9c1a-4c07e45e9e7c

Marketing Authorisation 38607022-3ef8c34b-2305-4dcc-8775-72e6a251f04c for PackagedProductDefinition 3ef8c34b-2305-4dcc-8775-72e6a251f04c

Reimbursement SL 9ad1447b-5864-4efa-aa6d-1789826af884 for PackagedProductDefinition 259e5e33-5cbb-47af-9c1a-4c07e45e9e7c

Reimbursement SL 80046cfb-f18f-4ee8-ac97-021e8f5830d0 for PackagedProductDefinition 3ef8c34b-2305-4dcc-8775-72e6a251f04c

Sulfadiazinum argenticum

Zur Anwendung im Spital. Wegen der Gefahr einer Keimübertragung soll die Spitalpackung jeweils nur für einen Patienten verwendet werden.


Marketing Authorisation 42045 for MedicinalProductDefinition ccb02be1-b911-4437-818b-087b160dda46

Flatulex Tropfen 41.2 mg/ml mit Dosierpumpe 50 ml

Marketing Authorisation 42045040-3c04d5b9-bade-41c9-b300-e5935b13ec61 for PackagedProductDefinition 3c04d5b9-bade-41c9-b300-e5935b13ec61

Reimbursement SL 2faae274-46b3-4a2c-a9ab-b5d9ef7f72f2 for PackagedProductDefinition 3c04d5b9-bade-41c9-b300-e5935b13ec61

Simeticonum


Marketing Authorisation 29792 for MedicinalProductDefinition 6ce19055-ed8f-4a5f-b647-e24d2bea62d3

Flatulex Kautabl 42 mg 50 Stk

Marketing Authorisation 29792046-14810235-be39-4f61-9858-d2be4b31bac6 for PackagedProductDefinition 14810235-be39-4f61-9858-d2be4b31bac6

Reimbursement SL 2d80cf8f-c595-4224-b9f1-76441885ee1f for PackagedProductDefinition 14810235-be39-4f61-9858-d2be4b31bac6

Simeticonum


07.10. Arthritis und rheumatische Krankheiten

Marketing Authorisation 57347 for MedicinalProductDefinition 11425f7c-28af-4db5-b286-cda62f50632e

Flectoparin Tissugel Pfl 7 Stk

Flectoparin Tissugel Pfl 10 Stk

Marketing Authorisation 57347008-3c521c42-4178-46cd-b92d-2d60dbc3519d for PackagedProductDefinition 3c521c42-4178-46cd-b92d-2d60dbc3519d

Marketing Authorisation 57347006-61b28777-0f34-456b-ba02-581fa0f973c8 for PackagedProductDefinition 61b28777-0f34-456b-ba02-581fa0f973c8

Reimbursement SL 268d70e6-7e95-4581-b162-e7aab770a18f for PackagedProductDefinition 3c521c42-4178-46cd-b92d-2d60dbc3519d

Reimbursement SL e0413c35-172a-426e-963a-a721b6e6ace8 for PackagedProductDefinition 61b28777-0f34-456b-ba02-581fa0f973c8

Diclofenacum epolaminum

Heparinum natricum


Marketing Authorisation 31095 for MedicinalProductDefinition 35fcc018-9998-4126-8606-074795fb1ffe

Florinef Tabl 0.1 mg 100 Stk

Marketing Authorisation 31095018-e898de92-2e9a-4e08-b191-475f7932b22b for PackagedProductDefinition e898de92-2e9a-4e08-b191-475f7932b22b

Reimbursement SL 76fd3fb9-71fd-43ba-bd3d-472b1de9c63a for PackagedProductDefinition e898de92-2e9a-4e08-b191-475f7932b22b

Fludrocortisoni acetas


11.07.10. Mittel gegen bakterielle Erreger

Marketing Authorisation 51357 for MedicinalProductDefinition ca197123-1cbc-4a2d-b78c-cc3693c0314a

Floxal Gtt Opht 0.3 % 5 ml

Marketing Authorisation 51357019-ddc69abf-f041-4b9a-8ffe-8fe4a2f93a30 for PackagedProductDefinition ddc69abf-f041-4b9a-8ffe-8fe4a2f93a30

Reimbursement SL 7435d19b-fb56-45eb-848a-a08ee98bf9ea for PackagedProductDefinition ddc69abf-f041-4b9a-8ffe-8fe4a2f93a30

Ofloxacinum


Marketing Authorisation 51358 for MedicinalProductDefinition 9ab83683-a1f2-4d62-bc5c-52f7510ebfe9

Floxal Augensalbe 0.3 % 3 g

Marketing Authorisation 51358015-7046a604-7bb8-4aaf-bcc8-2146b45aa701 for PackagedProductDefinition 7046a604-7bb8-4aaf-bcc8-2146b45aa701

Reimbursement SL 1f499f96-e706-4df3-ab21-ba7ead5ae019 for PackagedProductDefinition 7046a604-7bb8-4aaf-bcc8-2146b45aa701

Ofloxacinum


Marketing Authorisation 55383 for MedicinalProductDefinition dbbb7a20-9fde-4998-b7b8-5174f3ef586a

Floxal UD Gtt Opht 0.3 % 30 Unidos 0.5 ml

Marketing Authorisation 55383022-d2b687ce-b626-41a4-9ed6-93f3025c9e30 for PackagedProductDefinition d2b687ce-b626-41a4-9ed6-93f3025c9e30

Reimbursement SL 6d64a070-ba63-48a4-988d-3a3e05e1593c for PackagedProductDefinition d2b687ce-b626-41a4-9ed6-93f3025c9e30

Ofloxacinum


Marketing Authorisation 44603 for MedicinalProductDefinition 21b0533a-448b-4e5b-9288-d8520c986a83

Floxyfral Tabl 100 mg 30 Stk

Floxyfral Tabl 100 mg 60 Stk

Marketing Authorisation 44603071-0a3dac5a-6868-4860-b638-566b5c146c9b for PackagedProductDefinition 0a3dac5a-6868-4860-b638-566b5c146c9b

Marketing Authorisation 44603098-eb232cc8-9055-4ede-ac2f-b3fe5bce296c for PackagedProductDefinition eb232cc8-9055-4ede-ac2f-b3fe5bce296c

Reimbursement SL 3e15784b-d50d-4fec-8c46-4ad100056a2c for PackagedProductDefinition 0a3dac5a-6868-4860-b638-566b5c146c9b

Reimbursement SL cc07f3b4-344d-4f5a-b4b5-367346f410c3 for PackagedProductDefinition eb232cc8-9055-4ede-ac2f-b3fe5bce296c

Fluvoxamini maleas


Marketing Authorisation 44603 for MedicinalProductDefinition fcd38bb7-42c5-4fd2-ac8f-7ec30691bba4

Floxyfral Junior Filmtabl 50 mg 30 Stk

Floxyfral Junior Filmtabl 50 mg 100 Stk

Marketing Authorisation 44603055-8fd92beb-3a65-4d3d-8cdc-7aa064149375 for PackagedProductDefinition 8fd92beb-3a65-4d3d-8cdc-7aa064149375

Marketing Authorisation 44603063-e0fc4fe9-b6c0-48a7-8cf6-9c7725262020 for PackagedProductDefinition e0fc4fe9-b6c0-48a7-8cf6-9c7725262020

Reimbursement SL d4b1b187-4efa-45e1-b111-fae787e4152c for PackagedProductDefinition 8fd92beb-3a65-4d3d-8cdc-7aa064149375

Reimbursement SL d8f1daac-b89e-458d-bb69-7ec16fcc2ff6 for PackagedProductDefinition e0fc4fe9-b6c0-48a7-8cf6-9c7725262020

Fluvoxamini maleas


Marketing Authorisation 62047 for MedicinalProductDefinition 7f9ef57a-06e6-41e0-91cc-87528f2a3bb0

Fluanxol Filmtabl 0.5 mg 50 Stk

Marketing Authorisation 62047001-f37ac43c-a569-4c6b-8882-536de41e966d for PackagedProductDefinition f37ac43c-a569-4c6b-8882-536de41e966d

Reimbursement SL b519d9d0-bb1b-444f-890f-ab71d4e4da81 for PackagedProductDefinition f37ac43c-a569-4c6b-8882-536de41e966d

Flupentixolum


Marketing Authorisation 62047 for MedicinalProductDefinition a9a531c9-6102-43e3-ab11-536e36f34f20

Fluanxol Filmtabl 1 mg 50 Stk

Marketing Authorisation 62047002-b8ce3cce-6ab3-4496-9416-c459b28f0f0e for PackagedProductDefinition b8ce3cce-6ab3-4496-9416-c459b28f0f0e

Reimbursement SL 5ad3f410-2470-408f-99b3-938045c4c192 for PackagedProductDefinition b8ce3cce-6ab3-4496-9416-c459b28f0f0e

Flupentixolum


Marketing Authorisation 62047 for MedicinalProductDefinition 3af20d40-f466-42ac-bc26-b75ca8a43079

Fluanxol Filmtabl 5 mg 50 Stk

Marketing Authorisation 62047003-3771ab35-ec49-4ec7-aa84-d661b13d19dd for PackagedProductDefinition 3771ab35-ec49-4ec7-aa84-d661b13d19dd

Reimbursement SL f53f46cc-773d-4ed4-a176-a05962bcd551 for PackagedProductDefinition 3771ab35-ec49-4ec7-aa84-d661b13d19dd

Flupentixolum


Marketing Authorisation 35407 for MedicinalProductDefinition 5ac634f1-bc00-486f-9d37-61f7bc19c761

Fluanxol Depot 10 % Inj Lös 100 mg/ml Amp 1 ml

Marketing Authorisation 35407103-05b77ade-4cc4-4a0a-a87c-6be92af1f421 for PackagedProductDefinition 05b77ade-4cc4-4a0a-a87c-6be92af1f421

Reimbursement SL 0334e841-e771-436b-bc01-79a3ec0fa235 for PackagedProductDefinition 05b77ade-4cc4-4a0a-a87c-6be92af1f421

Flupentixoli decanoas


Marketing Authorisation 35407 for MedicinalProductDefinition 8c69645c-3263-4b1c-877c-129903837ad1

Fluanxol Depot 2 % Inj Lös 20 mg/ml Amp 1 ml

Marketing Authorisation 35407014-bdaadb3a-3144-4cc5-b1bb-c206ce65e65a for PackagedProductDefinition bdaadb3a-3144-4cc5-b1bb-c206ce65e65a

Reimbursement SL 95f28605-96b2-406e-8638-139d29966d2d for PackagedProductDefinition bdaadb3a-3144-4cc5-b1bb-c206ce65e65a

Flupentixoli decanoas


Influenza, inaktiviert, Spalt/Split Virus oder Oberflächen-Antigen

Fluarix Tetra susp inj av aig sép 2025/2026

Marketing Authorisation 62961 for MedicinalProductDefinition 7d43985b-1d0b-4a57-9ef9-dd546516cb35

Fluarix Tetra Inj Susp m sep Nad 2025/2026 Fertspr 0.5 ml

Marketing Authorisation 62961035-56e36c0b-7da8-4945-885c-cb0dd3baed88 for PackagedProductDefinition 56e36c0b-7da8-4945-885c-cb0dd3baed88

Reimbursement SL a1308765-ab04-4297-94d8-aaef4a53dc66 for PackagedProductDefinition 56e36c0b-7da8-4945-885c-cb0dd3baed88

Haemagglutininum influenzae

Die Kostenübernahme der Impfstoffe als Teil einer präventiven Massnahme im Rahmen der obligatorischen Krankenpflegeversicherung richtet sich nach den in Artikel 12a KLV für die jeweiligen Impfungen abschliessend festgelegten Voraussetzungen und erfolgt nur innerhalb der Zulassung durch Swissmedic. Bei beruflicher und reisemedizinischer Indikation erfolgt keine Kostenübernahme durch die obligatorische Krankenpflegeversicherung. Die Preise der Impfstoffe sind Höchstpreise (Art. 52 Abs. 3 KVG) und kommen bei Reihenimpfungen (z.B. im schulärztlichen Dienst) nicht zur Anwendung. In diesen Fällen gelten die von den Krankenversicherern mit den zuständigen Behörden ausgehandelten bzw. die allenfalls von den Behörden festgesetzten Tarife. Wenn der Impfstoff zu einem günstigeren Preis bezogen wird (z.B. im Rahmen von Reihenimpfungen), darf der Arzt oder die Ärztin nicht den Publikumspreis der SL verrechnen. Die Vergünstigung muss gemäss Artikel 56 Absatz 3 KVG weitergegeben werden, ausser es bestehen Vereinbarungen nach Artikel 56 Absatz 3bis KVG.


Flucelvax Tetra susp inj av aigu 2025/2026

Marketing Authorisation 67482 for MedicinalProductDefinition c8fdac64-bdfa-4a6e-8645-ac511f76d268

Flucelvax Tetra Inj Susp m Nadel 2025/2026 Fertspr 0.5 ml

Marketing Authorisation 67482009-4f9c5f98-a5d4-4ebf-9baa-442ab797344b for PackagedProductDefinition 4f9c5f98-a5d4-4ebf-9baa-442ab797344b

Reimbursement SL c7e59b55-0bb7-47f5-9b7c-06980e499c86 for PackagedProductDefinition 4f9c5f98-a5d4-4ebf-9baa-442ab797344b

Haemagglutininum influenzae

Kostenübernahme für Personen ab 2 Jahren gemäss Referenzdokument Prophylaktische Impfungen vom 01. Januar 2026.


Marketing Authorisation 58061 for MedicinalProductDefinition 8a558795-d688-4d78-9374-353d760de8be

Flucoderm Kaps 50 mg 7 Stk

Flucoderm Kaps 50 mg 28 Stk

Marketing Authorisation 58061002-40c52169-e279-42d8-bb6f-178f0648957a for PackagedProductDefinition 40c52169-e279-42d8-bb6f-178f0648957a

Marketing Authorisation 58061004-0598d7c6-8f1d-417f-a30d-a344e8a34474 for PackagedProductDefinition 0598d7c6-8f1d-417f-a30d-a344e8a34474

Reimbursement SL c4d92556-9806-4b05-8aae-a3738afa833d for PackagedProductDefinition 40c52169-e279-42d8-bb6f-178f0648957a

Reimbursement SL 9bb04ba4-9370-4eda-aff1-0e568ff14546 for PackagedProductDefinition 0598d7c6-8f1d-417f-a30d-a344e8a34474

Fluconazolum


Marketing Authorisation 58061 for MedicinalProductDefinition b31f6363-26d8-4627-894e-4e3605030649

Flucoderm Kaps 100 mg 4 Stk

Flucoderm Kaps 100 mg 7 Stk

Flucoderm Kaps 100 mg 14 Stk

Marketing Authorisation 58061006-f93b316c-484b-4e35-ae52-24635390e585 for PackagedProductDefinition f93b316c-484b-4e35-ae52-24635390e585

Marketing Authorisation 58061008-7349b53e-e290-4b2e-964a-a85cbb3717f2 for PackagedProductDefinition 7349b53e-e290-4b2e-964a-a85cbb3717f2

Marketing Authorisation 58061010-c419198a-24ea-4bae-9f01-4b9bc81a935f for PackagedProductDefinition c419198a-24ea-4bae-9f01-4b9bc81a935f

Reimbursement SL 85514b72-4985-4165-94ce-e30b5a1c0021 for PackagedProductDefinition f93b316c-484b-4e35-ae52-24635390e585

Reimbursement SL d75d9d59-7a0e-4200-bd85-f2b7e41b03f8 for PackagedProductDefinition 7349b53e-e290-4b2e-964a-a85cbb3717f2

Reimbursement SL 47b3d806-df73-4760-8720-107525fb2dac for PackagedProductDefinition c419198a-24ea-4bae-9f01-4b9bc81a935f

Fluconazolum


Marketing Authorisation 58061 for MedicinalProductDefinition 05943e09-6fb9-40e3-915c-9551c5586d79

Flucoderm Kaps 150 mg 1 Stk

Flucoderm Kaps 150 mg 4 Stk

Marketing Authorisation 58061012-7f46128b-bd91-4050-9bf8-79453ec85635 for PackagedProductDefinition 7f46128b-bd91-4050-9bf8-79453ec85635

Marketing Authorisation 58061014-a760ca34-5940-4bb1-8570-3d8f273bfe60 for PackagedProductDefinition a760ca34-5940-4bb1-8570-3d8f273bfe60

Reimbursement SL 25a7eb71-30f9-45c4-946c-0889a616c47a for PackagedProductDefinition 7f46128b-bd91-4050-9bf8-79453ec85635

Reimbursement SL e74313b4-54a8-4928-97bf-6207c433f4e9 for PackagedProductDefinition a760ca34-5940-4bb1-8570-3d8f273bfe60

Fluconazolum


Marketing Authorisation 58061 for MedicinalProductDefinition 1fb1574d-a713-41ae-aabb-cce1686c71ad

Flucoderm Kaps 200 mg 2 Stk

Flucoderm Kaps 200 mg 7 Stk

Marketing Authorisation 58061016-9405f250-3a4d-444b-afdf-c4a735412728 for PackagedProductDefinition 9405f250-3a4d-444b-afdf-c4a735412728

Reimbursement SL 44d16fce-0825-4751-9ca0-0c346c9d9c89 for PackagedProductDefinition 9405f250-3a4d-444b-afdf-c4a735412728

Reimbursement SL a7b3332e-2709-45da-abf3-d587c2cdd8e4 for PackagedProductDefinition d64404e5-0564-4047-8b47-a9314a6493aa

Fluconazolum


Marketing Authorisation 57182 for MedicinalProductDefinition e2b054af-d505-4909-86e9-8a9e188ceab0

Fluconax Kaps 50 mg 7 Stk

Fluconax Kaps 50 mg 28 Stk

Marketing Authorisation 57182001-09f89295-b34c-4e20-89ce-575ab85ad433 for PackagedProductDefinition 09f89295-b34c-4e20-89ce-575ab85ad433

Marketing Authorisation 57182003-0a7f470b-6d58-4bd9-a527-b63eaaa893ec for PackagedProductDefinition 0a7f470b-6d58-4bd9-a527-b63eaaa893ec

Reimbursement SL 323c55e5-eb56-4de4-b92c-3d4b9711e343 for PackagedProductDefinition 09f89295-b34c-4e20-89ce-575ab85ad433

Reimbursement SL 12316082-6116-489e-a5c6-64f14ada30ca for PackagedProductDefinition 0a7f470b-6d58-4bd9-a527-b63eaaa893ec

Fluconazolum


Marketing Authorisation 57182 for MedicinalProductDefinition 8e4b401a-680e-4c03-8396-2380be6a5d5d

Fluconax Kaps 150 mg 1 Stk

Fluconax Kaps 150 mg 4 Stk

Marketing Authorisation 57182007-18d498e7-0bc0-4a09-a4a6-240d7c2d25ed for PackagedProductDefinition 18d498e7-0bc0-4a09-a4a6-240d7c2d25ed

Marketing Authorisation 57182009-0528534a-8977-4f35-8a6d-6a70c98865cc for PackagedProductDefinition 0528534a-8977-4f35-8a6d-6a70c98865cc

Reimbursement SL 8a719fca-2c8c-4881-acf2-5b5a1f83bc49 for PackagedProductDefinition 18d498e7-0bc0-4a09-a4a6-240d7c2d25ed

Reimbursement SL 2ba9d067-bbc4-4604-9562-78e33dd73f6b for PackagedProductDefinition 0528534a-8977-4f35-8a6d-6a70c98865cc

Fluconazolum


Marketing Authorisation 57182 for MedicinalProductDefinition 4644b3f1-ce8b-48bb-94c3-03a6140424fa

Fluconax Kaps 200 mg 2 Stk

Fluconax Kaps 200 mg 7 Stk

Marketing Authorisation 57182013-a9ea0957-4fd7-4bd9-afa0-d546dd1f257e for PackagedProductDefinition a9ea0957-4fd7-4bd9-afa0-d546dd1f257e

Marketing Authorisation 57182015-103eb05b-c077-449c-a9d5-16f510336de4 for PackagedProductDefinition 103eb05b-c077-449c-a9d5-16f510336de4

Reimbursement SL b5063c62-e028-414f-8ffe-93ea46808569 for PackagedProductDefinition a9ea0957-4fd7-4bd9-afa0-d546dd1f257e

Reimbursement SL af59504a-6dcf-4eda-ac54-45485b2d73c4 for PackagedProductDefinition 103eb05b-c077-449c-a9d5-16f510336de4

Fluconazolum


Marketing Authorisation 58454 for MedicinalProductDefinition 88737f15-6fc9-43b7-bf8d-317f66296cd7

Fluconazol axapharm Kaps 50 mg 7 Stk

Fluconazol axapharm Kaps 50 mg 28 Stk

Marketing Authorisation 58454001-5af214e9-1607-482f-a9d2-ea26378fe1fe for PackagedProductDefinition 5af214e9-1607-482f-a9d2-ea26378fe1fe

Marketing Authorisation 58454003-f21413e1-9645-496b-945b-8481a2c3d8d5 for PackagedProductDefinition f21413e1-9645-496b-945b-8481a2c3d8d5

Reimbursement SL f70da140-e7ed-4a43-b384-62cd49895dfc for PackagedProductDefinition 5af214e9-1607-482f-a9d2-ea26378fe1fe

Reimbursement SL bf8d266d-d2e4-4a7b-b52c-576fce194141 for PackagedProductDefinition f21413e1-9645-496b-945b-8481a2c3d8d5

Fluconazolum


Marketing Authorisation 58454 for MedicinalProductDefinition cdcdcbf6-8726-45b4-b56a-9eb866eddb86

Fluconazol axapharm Kaps 150 mg 1 Stk

Fluconazol axapharm Kaps 150 mg 4 Stk

Marketing Authorisation 58454005-6679b831-48a6-4d82-8b4e-5afeda9db7ca for PackagedProductDefinition 6679b831-48a6-4d82-8b4e-5afeda9db7ca

Marketing Authorisation 58454007-2fce88fd-4993-409a-ae3f-a905c6c9a804 for PackagedProductDefinition 2fce88fd-4993-409a-ae3f-a905c6c9a804

Reimbursement SL 32ce99c4-7d7c-41c1-9c50-8166a9e29cf0 for PackagedProductDefinition 6679b831-48a6-4d82-8b4e-5afeda9db7ca

Reimbursement SL 5529fa48-9327-4390-a985-d3ab0c45aeef for PackagedProductDefinition 2fce88fd-4993-409a-ae3f-a905c6c9a804

Fluconazolum


Marketing Authorisation 58454 for MedicinalProductDefinition 84fc76ad-f811-45c4-b2a7-c8905b8961ed

Fluconazol axapharm Kaps 200 mg 2 Stk

Fluconazol axapharm Kaps 200 mg 7 Stk

Marketing Authorisation 58454009-c7d3f530-7801-455e-9441-000c26dd8a35 for PackagedProductDefinition c7d3f530-7801-455e-9441-000c26dd8a35

Marketing Authorisation 58454011-ce4c13d3-7521-4dc8-bb9f-9da1baebe425 for PackagedProductDefinition ce4c13d3-7521-4dc8-bb9f-9da1baebe425

Reimbursement SL 6d6b74ba-209e-405c-bf9d-39d768ccb3fb for PackagedProductDefinition c7d3f530-7801-455e-9441-000c26dd8a35

Reimbursement SL 1686fe01-ca0c-473d-9674-c8aeada36bc1 for PackagedProductDefinition ce4c13d3-7521-4dc8-bb9f-9da1baebe425

Fluconazolum


Marketing Authorisation 68461 for MedicinalProductDefinition e609046e-549a-4ab1-af08-ad3bd6e878df

Fluconazol-Mepha Teva Kaps 50 mg Blist 7 Stk

Fluconazol-Mepha Teva Kaps 50 mg Blist 28 Stk

Marketing Authorisation 68461001-0ab0a06e-e708-4445-8122-c0784cec313a for PackagedProductDefinition 0ab0a06e-e708-4445-8122-c0784cec313a

Reimbursement SL 5b396c57-c067-4394-9873-f23172d1e13d for PackagedProductDefinition 0ab0a06e-e708-4445-8122-c0784cec313a

Reimbursement SL 9ee5c33c-403b-4f64-9dd9-a30216a878b5 for PackagedProductDefinition 56719be0-31fb-4203-86c5-7504681cc813

Fluconazolum


Marketing Authorisation 68461 for MedicinalProductDefinition d7e5499b-0acb-4d3d-8151-1d0b64075a6d

Fluconazol-Mepha Teva Kaps 150 mg Blist 1 Stk

Fluconazol-Mepha Teva Kaps 150 mg Blist 4 Stk

Marketing Authorisation 68461005-702eebe7-6aa8-40bb-99f3-227fdca0c6a2 for PackagedProductDefinition 702eebe7-6aa8-40bb-99f3-227fdca0c6a2

Marketing Authorisation 68461006-3c9affba-24ea-49e6-9a8b-8865bf00b3d8 for PackagedProductDefinition 3c9affba-24ea-49e6-9a8b-8865bf00b3d8

Reimbursement SL 4a80e937-aa7e-4214-81bf-8356f5071542 for PackagedProductDefinition 702eebe7-6aa8-40bb-99f3-227fdca0c6a2

Reimbursement SL f93aa8ed-a1e4-4381-8e97-8040b9918717 for PackagedProductDefinition 3c9affba-24ea-49e6-9a8b-8865bf00b3d8

Fluconazolum


Marketing Authorisation 68461 for MedicinalProductDefinition 07fccae8-be79-4dbf-bb72-b4a4547ff33d

Fluconazol-Mepha Teva Kaps 200 mg Blist 2 Stk

Fluconazol-Mepha Teva Kaps 200 mg Blist 7 Stk

Marketing Authorisation 68461007-a171f098-45e2-47f3-85dd-24cdebbd6e85 for PackagedProductDefinition a171f098-45e2-47f3-85dd-24cdebbd6e85

Marketing Authorisation 68461008-2970f50f-bfd1-4856-a9f2-cb1c1ec632c8 for PackagedProductDefinition 2970f50f-bfd1-4856-a9f2-cb1c1ec632c8

Reimbursement SL 95f49b61-80fd-47d2-80c3-4407468203af for PackagedProductDefinition a171f098-45e2-47f3-85dd-24cdebbd6e85

Reimbursement SL 6054f20b-dc0a-44a8-b3ef-dd0eb4245acb for PackagedProductDefinition 2970f50f-bfd1-4856-a9f2-cb1c1ec632c8

Fluconazolum


Marketing Authorisation 56235 for MedicinalProductDefinition 2c0bbbc2-d01d-425f-bdc1-8aad7f007266

Fluconazol Sandoz eco Kaps 50 mg 7 Stk

Fluconazol Sandoz eco Kaps 50 mg 28 Stk

Marketing Authorisation 56235014-54061887-f9ef-4244-aba7-3155b8dec54d for PackagedProductDefinition 54061887-f9ef-4244-aba7-3155b8dec54d

Marketing Authorisation 56235016-b4fd0558-56e5-4311-badf-2a2ef79d0df1 for PackagedProductDefinition b4fd0558-56e5-4311-badf-2a2ef79d0df1

Reimbursement SL a37dd1dc-13cf-49d1-937e-9a3e83aaae48 for PackagedProductDefinition 54061887-f9ef-4244-aba7-3155b8dec54d

Reimbursement SL ed274b43-a779-47a3-8f71-29c7a403adf4 for PackagedProductDefinition b4fd0558-56e5-4311-badf-2a2ef79d0df1

Fluconazolum


Marketing Authorisation 56235 for MedicinalProductDefinition 9dcc8c1d-f41b-4aba-9267-6fd99ac73f75

Fluconazol Sandoz eco Kaps 150 mg 1 Stk

Fluconazol Sandoz eco Kaps 150 mg 4 Stk

Marketing Authorisation 56235018-059a0b6d-fb53-4d0d-9b40-53a1d1977d6d for PackagedProductDefinition 059a0b6d-fb53-4d0d-9b40-53a1d1977d6d

Marketing Authorisation 56235020-df6e18e4-c234-4063-a19f-5692e3b39fbc for PackagedProductDefinition df6e18e4-c234-4063-a19f-5692e3b39fbc

Reimbursement SL 1406583e-84c4-4ccf-a4d3-786650057f51 for PackagedProductDefinition 059a0b6d-fb53-4d0d-9b40-53a1d1977d6d

Reimbursement SL fc26c17c-d2fd-44d9-bdd5-881d058f5ed4 for PackagedProductDefinition df6e18e4-c234-4063-a19f-5692e3b39fbc

Fluconazolum


Marketing Authorisation 56235 for MedicinalProductDefinition 866a5a32-6f4f-41ba-ab39-181cb355affd

Fluconazol Sandoz eco Kaps 200 mg 2 Stk

Fluconazol Sandoz eco Kaps 200 mg 7 Stk

Marketing Authorisation 56235022-8f16d4c0-97d2-4605-a31e-27809b447e09 for PackagedProductDefinition 8f16d4c0-97d2-4605-a31e-27809b447e09

Marketing Authorisation 56235024-473fc30d-5922-4072-a4c7-0dcdad010e7f for PackagedProductDefinition 473fc30d-5922-4072-a4c7-0dcdad010e7f

Reimbursement SL cf6404bc-094c-428e-90c2-c835c4e91199 for PackagedProductDefinition 8f16d4c0-97d2-4605-a31e-27809b447e09

Reimbursement SL e5bc1b54-ba06-4083-ab64-e852a272e786 for PackagedProductDefinition 473fc30d-5922-4072-a4c7-0dcdad010e7f

Fluconazolum


Marketing Authorisation 56978 for MedicinalProductDefinition f4d7ee95-de0c-463b-8eff-1e8c0cb54e64

Fluconazol Zentiva Kaps 50 mg Blist 7 Stk

Fluconazol Zentiva Kaps 50 mg Blist 28 Stk

Marketing Authorisation 56978002-4d1ccf3e-8e0c-408a-a319-d96cc52e7243 for PackagedProductDefinition 4d1ccf3e-8e0c-408a-a319-d96cc52e7243

Marketing Authorisation 56978004-4118755d-9b57-4f4e-8e6a-fff35eebf271 for PackagedProductDefinition 4118755d-9b57-4f4e-8e6a-fff35eebf271

Reimbursement SL 5461c489-ba58-475d-a448-cac6f3f2fbde for PackagedProductDefinition 4d1ccf3e-8e0c-408a-a319-d96cc52e7243

Reimbursement SL 3b2c4ab2-814e-4b17-bb24-8648107bd4b6 for PackagedProductDefinition 4118755d-9b57-4f4e-8e6a-fff35eebf271

Fluconazolum


Marketing Authorisation 56978 for MedicinalProductDefinition d47a59cc-c2cb-43c4-bd7a-e75c9015263c

Fluconazol Zentiva Kaps 150 mg Blist 1 Stk

Fluconazol Zentiva Kaps 150 mg Blist 4 Stk

Marketing Authorisation 56978006-97278795-fc2d-4a40-a821-74385d1cf936 for PackagedProductDefinition 97278795-fc2d-4a40-a821-74385d1cf936

Reimbursement SL 976249d6-3772-47b7-8a0a-aa2a0400261e for PackagedProductDefinition 97278795-fc2d-4a40-a821-74385d1cf936

Fluconazolum


Marketing Authorisation 56978 for MedicinalProductDefinition 553f290a-8e99-465b-9825-c0cdf2e8fb9b

Fluconazol Zentiva Kaps 200 mg Blist 2 Stk

Fluconazol Zentiva Kaps 200 mg Blist 7 Stk

Marketing Authorisation 56978010-3f3254b2-9da0-4a9e-bdce-8233dc41a38b for PackagedProductDefinition 3f3254b2-9da0-4a9e-bdce-8233dc41a38b

Marketing Authorisation 56978012-237da18a-cdb4-4f23-acc8-48b17be2ff3c for PackagedProductDefinition 237da18a-cdb4-4f23-acc8-48b17be2ff3c

Reimbursement SL 72285476-66f9-4cb9-9521-21f6bf3b63dd for PackagedProductDefinition 3f3254b2-9da0-4a9e-bdce-8233dc41a38b

Reimbursement SL bbddd96d-ecb7-4f6f-959b-3540687efe0d for PackagedProductDefinition 237da18a-cdb4-4f23-acc8-48b17be2ff3c

Fluconazolum


Marketing Authorisation 46347 for MedicinalProductDefinition 2f50d254-fb39-4506-837a-d39c93b7ef2e

Fluctine Hartkaps 20 mg 30 Stk

Fluctine Hartkaps 20 mg 100 Stk

Marketing Authorisation 46347013-bf4327b1-03e2-4678-9ced-bdfc6006cd74 for PackagedProductDefinition bf4327b1-03e2-4678-9ced-bdfc6006cd74

Marketing Authorisation 46347021-31c5e28d-42ed-48b4-911f-877be81f3e83 for PackagedProductDefinition 31c5e28d-42ed-48b4-911f-877be81f3e83

Reimbursement SL dc5c6587-9430-4ddf-8fb2-9bff8e707a0d for PackagedProductDefinition bf4327b1-03e2-4678-9ced-bdfc6006cd74

Reimbursement SL 2165b0c8-e7b1-484f-b51a-e528f74d1c94 for PackagedProductDefinition 31c5e28d-42ed-48b4-911f-877be81f3e83

Fluoxetinum


Marketing Authorisation 66750 for MedicinalProductDefinition d2eee5c1-b981-4f40-818c-6255b7e1588d

Fludarabin Accord Inf Konz 50 mg/2ml Durchstf 1 Stk

Marketing Authorisation 66750001-061043d8-6a22-4c81-8144-a2affc10646a for PackagedProductDefinition 061043d8-6a22-4c81-8144-a2affc10646a

Reimbursement SL 5ca5decf-7456-4705-a2b9-7b3683d7d11e for PackagedProductDefinition 061043d8-6a22-4c81-8144-a2affc10646a

Fludarabini phosphas

Therapie der chronisch-lymphatischen Leukämie (CLL) vom B-Zell-Typ. Die Firstline-Therapie mit Fludarabin sollte nur bei Patienten mit fortgeschrittener Erkrankung begonnen werden, d.h. im Binet-Stadium B oder C, einhergehend mit krankheitsbedingten Symptomen oder Zeichen einer Krankheitsprogression. Behandlung des niedrig malignen Non-Hodgkin-Lymphoms im Stadium 3 bis 4 bei Patienten, die auf eine Standardtherapie mit mindestens einer alkylierenden Substanz nicht angesprochen haben oder bei denen die Krankheit während oder nach der Standardtherapie fortgeschritten ist.


Marketing Authorisation 58535 for MedicinalProductDefinition b911a7b3-6f62-4783-96c8-4c68356d0b31

Fludarabin-Teva Inf Konz 50 mg/2ml Durchstf 2 ml

Marketing Authorisation 58535001-f0c33fb2-b1b8-4f79-ad2b-6e7f35fb7191 for PackagedProductDefinition f0c33fb2-b1b8-4f79-ad2b-6e7f35fb7191

Reimbursement SL c01bf9c5-c300-4244-b127-3fb4f97988a9 for PackagedProductDefinition f0c33fb2-b1b8-4f79-ad2b-6e7f35fb7191

Fludarabini phosphas


02.07.10. Einfache blutdrucksenkende Mittel

Marketing Authorisation 53975 for MedicinalProductDefinition 403806e7-ad0c-4894-b8cf-a446ff905506

Fludex SR Tabl 1.5 mg 30 Stk

Fludex SR Tabl 1.5 mg 90 Stk

Marketing Authorisation 53975011-3ab959e1-e48b-4128-a7ed-6a070e6c07d1 for PackagedProductDefinition 3ab959e1-e48b-4128-a7ed-6a070e6c07d1

Marketing Authorisation 53975038-1eabfd36-c363-4e5c-9c07-ae43d549d81f for PackagedProductDefinition 1eabfd36-c363-4e5c-9c07-ae43d549d81f

Reimbursement SL 5405ce91-fa8c-4352-94c8-571281f1922c for PackagedProductDefinition 3ab959e1-e48b-4128-a7ed-6a070e6c07d1

Reimbursement SL be07c8cd-5e2c-4356-bcd8-f4ba6bd433e5 for PackagedProductDefinition 1eabfd36-c363-4e5c-9c07-ae43d549d81f

Indapamidum


Künstliche Tränenflüssigkeit und sonstige indifferente Präparate

Marketing Authorisation 57779 for MedicinalProductDefinition 6485e6d5-0a5d-4fbc-ae4f-8e9576d4dccc

Fluidose Gtt Opht 30 Monodos 0.4 ml

Marketing Authorisation 57779006-4ae3b931-4fca-46e8-a36d-c72a5926dbd5 for PackagedProductDefinition 4ae3b931-4fca-46e8-a36d-c72a5926dbd5

Reimbursement SL 8bcc1da6-2b4f-48fe-8bba-5ab726e520fc for PackagedProductDefinition 4ae3b931-4fca-46e8-a36d-c72a5926dbd5

Carbomerum 980


Marketing Authorisation 57279 for MedicinalProductDefinition 269a8dc1-c607-4495-96f0-191f76b9db2a

Fluimucil Tabl 600 mg 12 Stk

Fluimucil Tabl 600 mg 30 Stk

Fluimucil Tabl 600 mg 60 Stk

Marketing Authorisation 57279016-1a790e19-77a7-4a12-972d-e7467b3680f2 for PackagedProductDefinition 1a790e19-77a7-4a12-972d-e7467b3680f2

Marketing Authorisation 57279018-bc290c2a-868e-49ed-9c6c-8e4960ba0619 for PackagedProductDefinition bc290c2a-868e-49ed-9c6c-8e4960ba0619

Marketing Authorisation 57279017-4538e2dd-9410-448d-b56e-41bb77b443a5 for PackagedProductDefinition 4538e2dd-9410-448d-b56e-41bb77b443a5

Reimbursement SL 341af799-ad1b-402e-ac4e-d4e28d9eff05 for PackagedProductDefinition 1a790e19-77a7-4a12-972d-e7467b3680f2

Reimbursement SL ab4bc64f-7d7f-4b5d-a8dc-910f8ec6e599 for PackagedProductDefinition bc290c2a-868e-49ed-9c6c-8e4960ba0619

Reimbursement SL ce08efb4-92b6-4d88-88e7-2766bcb38f54 for PackagedProductDefinition 4538e2dd-9410-448d-b56e-41bb77b443a5

Acetylcysteinum

Zur Langzeitbehandlung von chronischer Bronchitis, Therapiedauer maximal 3 - 6 Monate, und zur Behandlung von Mukoviszidose.


Marketing Authorisation 37561 for MedicinalProductDefinition 0bbd609e-6554-4ead-8e88-df32207742cc

Fluimucil Gran 100 mg Kind Btl 30 Stk

Marketing Authorisation 37561001-3f62191c-4aaa-4b4f-985d-b1a9e56d0a7f for PackagedProductDefinition 3f62191c-4aaa-4b4f-985d-b1a9e56d0a7f

Reimbursement SL 58057d2a-f899-46ca-998a-388276de920d for PackagedProductDefinition 3f62191c-4aaa-4b4f-985d-b1a9e56d0a7f

Acetylcysteinum


Marketing Authorisation 37561 for MedicinalProductDefinition 248444f8-dff7-491b-b3e3-0e79db41c15b

Fluimucil Gran 200 mg Erw Btl 30 Stk

Fluimucil Gran 200 mg Erw Btl 90 Stk

Marketing Authorisation 37561002-91ae538f-1de9-4cbf-920b-113729104194 for PackagedProductDefinition 91ae538f-1de9-4cbf-920b-113729104194

Marketing Authorisation 37561003-86a3cc34-2f37-47e7-87b1-467361fcce63 for PackagedProductDefinition 86a3cc34-2f37-47e7-87b1-467361fcce63

Reimbursement SL 86ec67fd-427c-45bf-9791-98c65b2fe7bb for PackagedProductDefinition 91ae538f-1de9-4cbf-920b-113729104194

Reimbursement SL a22af478-0596-4b57-b901-6c641c72fa8a for PackagedProductDefinition 86a3cc34-2f37-47e7-87b1-467361fcce63

Acetylcysteinum


Marketing Authorisation 37561 for MedicinalProductDefinition 715a4eaa-ce9d-4e76-81cf-c9ec20101cbd

Fluimucil Gran 600 mg Btl 30 Stk

Marketing Authorisation 37561005-e12d7210-fcc1-450d-82cd-f7765d6ae66b for PackagedProductDefinition e12d7210-fcc1-450d-82cd-f7765d6ae66b

Reimbursement SL c467172f-6b86-4e48-8b6e-9f6a11240ba0 for PackagedProductDefinition e12d7210-fcc1-450d-82cd-f7765d6ae66b

Acetylcysteinum


Marketing Authorisation 66860 for MedicinalProductDefinition 86421d34-5541-4842-8bfd-faa06778e590

Fluimucil 10% Inj Lös 300 mg/3ml 5 Amp 3 ml

Marketing Authorisation 66860010-d03acd6d-9381-4cda-8f85-85613d5c586e for PackagedProductDefinition d03acd6d-9381-4cda-8f85-85613d5c586e

Reimbursement SL 391799e8-3f4b-4ac0-90ac-af16eb4d181a for PackagedProductDefinition d03acd6d-9381-4cda-8f85-85613d5c586e

Acetylcysteinum


Fluimucil 600 cpr eff 600 mg adult citron

Marketing Authorisation 45179 for MedicinalProductDefinition 79a19cf1-8cd2-41dc-bda6-b96b6f85c8a0

Fluimucil 600 Brausetabl 600 mg Erw citron 10 Stk

Fluimucil 600 Brausetabl 600 mg Erw citron 30 Stk

Fluimucil 600 Brausetabl 600 mg Erw citron 100 Stk

Marketing Authorisation 45179079-2874cbad-5a14-4af3-bd4f-58675c65040b for PackagedProductDefinition 2874cbad-5a14-4af3-bd4f-58675c65040b

Marketing Authorisation 45179095-9e968aeb-265d-4aeb-9001-84f43b87495a for PackagedProductDefinition 9e968aeb-265d-4aeb-9001-84f43b87495a

Marketing Authorisation 45179126-5c7d657a-50f8-4bcf-938a-ae110391411f for PackagedProductDefinition 5c7d657a-50f8-4bcf-938a-ae110391411f

Reimbursement SL 46bda4ce-4ee3-45c1-90e8-c133444baeb0 for PackagedProductDefinition 2874cbad-5a14-4af3-bd4f-58675c65040b

Reimbursement SL b7a75576-2594-4eda-8ff7-47f66edaeedc for PackagedProductDefinition 9e968aeb-265d-4aeb-9001-84f43b87495a

Reimbursement SL d5e4f4fd-aa37-4fe4-b16e-e3dfd893d3e7 for PackagedProductDefinition 5c7d657a-50f8-4bcf-938a-ae110391411f

Acetylcysteinum

Zur Langzeitbehandlung von chronischer Bronchitis, Therapiedauer maximal 3 - 6 Monate, und zur Behandlung von Mukoviszidose.


Marketing Authorisation 55919 for MedicinalProductDefinition df90a03d-ffa8-44a1-be5b-b4a689f15cb0

Fluomizin Vag Tabl 10 mg 6 Stk

Marketing Authorisation 55919008-f3af6acb-2dfa-4178-ad9b-ebd00e145604 for PackagedProductDefinition f3af6acb-2dfa-4178-ad9b-ebd00e145604

Reimbursement SL 0a12981a-39e5-4893-b8df-892d70b74c93 for PackagedProductDefinition f3af6acb-2dfa-4178-ad9b-ebd00e145604

Dequalinii chloridum


Marketing Authorisation 66825 for MedicinalProductDefinition e1dece60-0270-4726-95cd-52fd4d93fa20

Fluorouracil Accord Inj Lös 250 mg/5ml Durchstf 5 ml

Marketing Authorisation 66825001-3b9b7900-e9d9-436e-a403-e54a17468f53 for PackagedProductDefinition 3b9b7900-e9d9-436e-a403-e54a17468f53

Reimbursement SL 9fb070ff-d4f6-41c2-9c90-0b39013ab1c6 for PackagedProductDefinition 3b9b7900-e9d9-436e-a403-e54a17468f53

Fluorouracilum


Marketing Authorisation 66825 for MedicinalProductDefinition 9545699d-d8cd-470d-88e0-ca8d2368b434

Fluorouracil Accord Inj Lös 500 mg/10ml Durchstf 10 ml

Marketing Authorisation 66825002-432cf3cb-35ec-4c05-aca2-bda46ceda214 for PackagedProductDefinition 432cf3cb-35ec-4c05-aca2-bda46ceda214

Reimbursement SL 7d2289f2-a911-4a2a-a1ed-4d48626a9198 for PackagedProductDefinition 432cf3cb-35ec-4c05-aca2-bda46ceda214

Fluorouracilum


Fluorouracil Accord sol inj 1000 mg/20ml

Marketing Authorisation 66825 for MedicinalProductDefinition d8d67832-7ece-4525-8796-15bb326bc577

Fluorouracil Accord Inj Lös 1000 mg/20ml Durchstf 20 ml

Marketing Authorisation 66825003-2662e190-c9b7-4f91-b739-0e4b9f55c849 for PackagedProductDefinition 2662e190-c9b7-4f91-b739-0e4b9f55c849

Reimbursement SL 18e7f1d0-ad59-4718-b333-e1837a1a9747 for PackagedProductDefinition 2662e190-c9b7-4f91-b739-0e4b9f55c849

Fluorouracilum


Fluorouracil Accord sol inj 2500 mg/50ml

Marketing Authorisation 66825 for MedicinalProductDefinition 1d18812c-3bae-4f54-b049-26f89796f759

Fluorouracil Accord Inj Lös 2500 mg/50ml Durchstf 50 ml

Marketing Authorisation 66825004-3ee9723f-2e45-4ca0-b7d4-e2ed663e8ba6 for PackagedProductDefinition 3ee9723f-2e45-4ca0-b7d4-e2ed663e8ba6

Reimbursement SL 0498303f-24e6-4de1-a4bc-1feb39af68ca for PackagedProductDefinition 3ee9723f-2e45-4ca0-b7d4-e2ed663e8ba6

Fluorouracilum


Fluorouracil Accord sol inj 5000 mg/100ml

Marketing Authorisation 66825 for MedicinalProductDefinition 946c65e1-dbd4-45be-9ee0-c02ca07fd164

Fluorouracil Accord Inj Lös 5000 mg/100ml Durchstf 100 ml

Marketing Authorisation 66825005-9c0d0014-91af-4037-b5a6-35502161a0c9 for PackagedProductDefinition 9c0d0014-91af-4037-b5a6-35502161a0c9

Reimbursement SL 80c9eaa5-1450-4ef1-91f1-40f5acd51bec for PackagedProductDefinition 9c0d0014-91af-4037-b5a6-35502161a0c9

Fluorouracilum


Marketing Authorisation 65688 for MedicinalProductDefinition 88551bad-6b97-425a-8166-fd1a9d9b635c

Fluorouracil Labatec Inj Lös 250 mg/5ml Durchstf 5 ml

Marketing Authorisation 65688001-f4e6e5de-bcea-4670-bb4f-a077333eecfe for PackagedProductDefinition f4e6e5de-bcea-4670-bb4f-a077333eecfe

Reimbursement SL 4e64570c-388e-4e99-ab50-e10fa53043f4 for PackagedProductDefinition f4e6e5de-bcea-4670-bb4f-a077333eecfe

Fluorouracilum


Fluorouracil Labatec sol inj 500 mg/10ml

Marketing Authorisation 65688 for MedicinalProductDefinition 1e74fc64-9927-425b-8e6d-8f550dbd26c3

Fluorouracil Labatec Inj Lös 500 mg/10ml Durchstf 10 ml

Marketing Authorisation 65688002-d07cafb7-87a8-490b-aaa5-cda240f8def2 for PackagedProductDefinition d07cafb7-87a8-490b-aaa5-cda240f8def2

Reimbursement SL a6d86421-61b2-4b71-a3ad-c4f5fd1d313e for PackagedProductDefinition d07cafb7-87a8-490b-aaa5-cda240f8def2

Fluorouracilum


Fluorouracil Labatec sol inj 1000 mg/20ml

Marketing Authorisation 65688 for MedicinalProductDefinition d15107fd-1407-4913-9d36-f7350e8d60a9

Fluorouracil Labatec Inj Lös 1000 mg/20ml 20 ml

Marketing Authorisation 65688003-cc32adaa-fec1-4336-ba27-db85f8c7c307 for PackagedProductDefinition cc32adaa-fec1-4336-ba27-db85f8c7c307

Reimbursement SL 4f886cbb-56d1-4661-9623-e62796ab67e2 for PackagedProductDefinition cc32adaa-fec1-4336-ba27-db85f8c7c307

Fluorouracilum


Fluorouracil Labatec sol inj 5000 mg/100ml

Marketing Authorisation 65688 for MedicinalProductDefinition 97eca40a-1802-4d8a-986c-0d6a30b7dbbe

Fluorouracil Labatec Inj Lös 5000 mg/100ml Durchstf 100 ml

Marketing Authorisation 65688004-67c7203b-87fe-4fef-865b-a61794b6a6b5 for PackagedProductDefinition 67c7203b-87fe-4fef-865b-a61794b6a6b5

Reimbursement SL 676dd23e-f717-4131-ac49-9bc70deffeb5 for PackagedProductDefinition 67c7203b-87fe-4fef-865b-a61794b6a6b5

Fluorouracilum


Marketing Authorisation 60186 for MedicinalProductDefinition 223d79b7-aecf-44df-9a9b-93268bc79149

Fluorouracil Sandoz Inj Lös 250 mg/5ml Durchstf 5 ml

Marketing Authorisation 60186006-b2fbfc8f-f3f6-47c8-a305-2fe81630fe9b for PackagedProductDefinition b2fbfc8f-f3f6-47c8-a305-2fe81630fe9b

Reimbursement SL 3b49dd18-5cea-4dea-8f6a-177e94ed031c for PackagedProductDefinition b2fbfc8f-f3f6-47c8-a305-2fe81630fe9b

Fluorouracilum


Fluorouracile Sandoz sol inj 500 mg/10ml

Marketing Authorisation 60186 for MedicinalProductDefinition 0d05a9cf-a746-4289-a793-7807ff5727cd

Fluorouracil Sandoz Inj Lös 500 mg/10ml Durchstf 10 ml

Marketing Authorisation 60186007-f093d8b8-7413-4127-9f95-26354abd5baf for PackagedProductDefinition f093d8b8-7413-4127-9f95-26354abd5baf

Reimbursement SL 9ac9d0fd-be2d-4af0-af04-4b82f14a4e7d for PackagedProductDefinition f093d8b8-7413-4127-9f95-26354abd5baf

Fluorouracilum


Fluorouracile Sandoz sol inj 1000 mg/20ml

Marketing Authorisation 60186 for MedicinalProductDefinition 3c12a330-8aec-4984-8406-47100e505e56

Fluorouracil Sandoz Inj Lös 1000 mg/20ml Durchstf 20 ml

Reimbursement SL fcd7fecf-7064-4d3e-b638-f5f858c66f94 for PackagedProductDefinition 7d83896b-8d90-481d-89a1-e82863521082

Fluorouracilum


Fluorouracile Sandoz sol inj 5000 mg/100ml

Marketing Authorisation 60186 for MedicinalProductDefinition 170b967c-6471-410e-8f81-45a05ec3f8fb

Fluorouracil Sandoz Inj Lös 5000 mg/100ml Durchstf 100 ml

Marketing Authorisation 60186010-63907ac5-7d65-4bed-a618-139e303e70c9 for PackagedProductDefinition 63907ac5-7d65-4bed-a618-139e303e70c9

Reimbursement SL d71a28f4-2943-4227-b43d-d8ee6fde2daf for PackagedProductDefinition 63907ac5-7d65-4bed-a618-139e303e70c9

Fluorouracilum


Marketing Authorisation 47160 for MedicinalProductDefinition 078c3b2a-0eba-45f6-892b-5d82fe95ab8b

Fluorouracil-Teva Inj Lös 250 mg/5ml Durchstf 5 ml

Marketing Authorisation 47160154-28cf163f-c8ed-4e67-9816-9e395994a8b3 for PackagedProductDefinition 28cf163f-c8ed-4e67-9816-9e395994a8b3

Reimbursement SL e5b7a684-a22c-4fe0-b58e-df8556dfb0eb for PackagedProductDefinition 28cf163f-c8ed-4e67-9816-9e395994a8b3

Fluorouracilum


Marketing Authorisation 47160 for MedicinalProductDefinition 28347435-d0b8-4410-8edf-c4f59efa547f

Fluorouracil-Teva Inj Lös 500 mg/10ml Durchstf 10 ml

Marketing Authorisation 47160162-bca7c1c7-3ca0-494e-8298-9e2d814684f1 for PackagedProductDefinition bca7c1c7-3ca0-494e-8298-9e2d814684f1

Reimbursement SL 171750f4-22c5-42e4-895b-10e05cc41efd for PackagedProductDefinition bca7c1c7-3ca0-494e-8298-9e2d814684f1

Fluorouracilum


Marketing Authorisation 47160 for MedicinalProductDefinition 6ed54f8d-d695-4a5d-a4e5-59a471438b5d

Fluorouracil-Teva Inj Lös 1000 mg/20ml Durchstf 20 ml

Marketing Authorisation 47160170-90bc85dd-d2a9-4e9f-a104-dbb73673efd4 for PackagedProductDefinition 90bc85dd-d2a9-4e9f-a104-dbb73673efd4

Reimbursement SL 2708b1bd-5888-4fa7-bd73-3a03a44583f2 for PackagedProductDefinition 90bc85dd-d2a9-4e9f-a104-dbb73673efd4

Fluorouracilum


Marketing Authorisation 47160 for MedicinalProductDefinition 367a2f72-dd7a-4460-89ae-466b4bbca13f

Fluorouracil-Teva Inj Lös 5000 mg/100ml Durchstf 100 ml

Marketing Authorisation 47160171-7270a37e-f422-4558-99af-612e76d4958f for PackagedProductDefinition 7270a37e-f422-4558-99af-612e76d4958f

Reimbursement SL e12a7416-3dd6-4acb-b750-28e5975f61e6 for PackagedProductDefinition 7270a37e-f422-4558-99af-612e76d4958f

Fluorouracilum


Marketing Authorisation 67152 for MedicinalProductDefinition 8a170703-4e1f-4808-84e6-9848ae9e550e

Fluoxetin axapharm Filmtabl 20 mg Blist 30 Stk

Fluoxetin axapharm Filmtabl 20 mg Blist 100 Stk

Marketing Authorisation 67152001-47fe38aa-4365-47d4-b871-5409483fc54d for PackagedProductDefinition 47fe38aa-4365-47d4-b871-5409483fc54d

Marketing Authorisation 67152002-68fb9c40-250f-48cf-9a74-3d6ce6519883 for PackagedProductDefinition 68fb9c40-250f-48cf-9a74-3d6ce6519883

Reimbursement SL 916bc31f-2cf3-471a-bbf4-588fba8899d4 for PackagedProductDefinition 47fe38aa-4365-47d4-b871-5409483fc54d

Reimbursement SL f29cf565-c11c-4434-b021-8b15aea404e8 for PackagedProductDefinition 68fb9c40-250f-48cf-9a74-3d6ce6519883

Fluoxetinum


Marketing Authorisation 54049 for MedicinalProductDefinition c41bf9aa-1f26-4de0-a722-b739f3d617d5

Fluoxetin-Mepha Kaps 20 mg 14 Stk

Fluoxetin-Mepha Kaps 20 mg 30 Stk

Fluoxetin-Mepha Kaps 20 mg 100 Stk

Marketing Authorisation 54049013-2833479f-c197-4bf5-98b7-67e47211f5bf for PackagedProductDefinition 2833479f-c197-4bf5-98b7-67e47211f5bf

Marketing Authorisation 54049021-8b1d66e9-bbbd-4d2d-a245-ff6f2755f0f1 for PackagedProductDefinition 8b1d66e9-bbbd-4d2d-a245-ff6f2755f0f1

Marketing Authorisation 54049048-ef9a36b9-4800-4094-b05e-938a30617a3b for PackagedProductDefinition ef9a36b9-4800-4094-b05e-938a30617a3b

Reimbursement SL f052fca9-f471-485a-bbe4-c74234ff775b for PackagedProductDefinition 2833479f-c197-4bf5-98b7-67e47211f5bf

Reimbursement SL 1a1915ef-336a-4580-be44-e4f67b07564c for PackagedProductDefinition 8b1d66e9-bbbd-4d2d-a245-ff6f2755f0f1

Reimbursement SL af6f944b-0591-4913-9ea2-d3102a28534f for PackagedProductDefinition ef9a36b9-4800-4094-b05e-938a30617a3b

Fluoxetinum


Marketing Authorisation 57235 for MedicinalProductDefinition db50e3d7-6d10-43ac-8fa4-6feaf8682244

Fluoxetin-Mepha Dispersible Tabl 20 mg 10 Stk

Fluoxetin-Mepha Dispersible Tabl 20 mg 30 Stk

Fluoxetin-Mepha Dispersible Tabl 20 mg 100 Stk

Marketing Authorisation 57235004-f4d45712-991e-4ac0-855e-4105e0ec9353 for PackagedProductDefinition f4d45712-991e-4ac0-855e-4105e0ec9353

Marketing Authorisation 57235010-4765adee-5e53-4176-ad5f-234f7d57e68f for PackagedProductDefinition 4765adee-5e53-4176-ad5f-234f7d57e68f

Marketing Authorisation 57235016-59ddccdd-18e7-422a-8d31-59de0946fb68 for PackagedProductDefinition 59ddccdd-18e7-422a-8d31-59de0946fb68

Reimbursement SL 684b788d-a47d-4553-986f-b0b254a899a4 for PackagedProductDefinition f4d45712-991e-4ac0-855e-4105e0ec9353

Reimbursement SL 88689f09-485e-4c4f-aa5b-4c1cc47a110d for PackagedProductDefinition 4765adee-5e53-4176-ad5f-234f7d57e68f

Reimbursement SL 450ae183-7540-4ff9-85b6-1cc8e83ca61c for PackagedProductDefinition 59ddccdd-18e7-422a-8d31-59de0946fb68

Fluoxetinum


Marketing Authorisation 54469 for MedicinalProductDefinition a8dc7b47-62ed-4309-979d-e77289f5d560

Fluoxetin Sandoz eco Kaps 20 mg 14 Stk

Fluoxetin Sandoz eco Kaps 20 mg 30 Stk

Fluoxetin Sandoz eco Kaps 20 mg 100 Stk

Marketing Authorisation 54469048-e29783e2-76bc-40ba-882a-eba32b5cbc9a for PackagedProductDefinition e29783e2-76bc-40ba-882a-eba32b5cbc9a

Marketing Authorisation 54469049-cbec0b09-7d26-4ccd-966e-9f1a4df279ac for PackagedProductDefinition cbec0b09-7d26-4ccd-966e-9f1a4df279ac

Marketing Authorisation 54469050-e1306c0d-e98a-4dc1-b5d9-67259d471ce1 for PackagedProductDefinition e1306c0d-e98a-4dc1-b5d9-67259d471ce1

Reimbursement SL be9a8d91-d613-43b6-8914-81668660d898 for PackagedProductDefinition e29783e2-76bc-40ba-882a-eba32b5cbc9a

Reimbursement SL 686c79fb-b42b-490c-afc7-d91f0619b83d for PackagedProductDefinition cbec0b09-7d26-4ccd-966e-9f1a4df279ac

Reimbursement SL 96ce23ae-3040-402f-821e-1f5e73f41715 for PackagedProductDefinition e1306c0d-e98a-4dc1-b5d9-67259d471ce1

Fluoxetinum


Marketing Authorisation 60485 for MedicinalProductDefinition 7d87d952-d313-4b5d-b171-cc28d705e394

Fluoxetin Spirig HC Kaps 20 mg 30 Stk

Fluoxetin Spirig HC Kaps 20 mg 100 Stk

Marketing Authorisation 60485004-1645e915-e9b3-4b37-86e9-9031abb96410 for PackagedProductDefinition 1645e915-e9b3-4b37-86e9-9031abb96410

Reimbursement SL ccb37c1f-8e13-425e-abe3-1e3fa9864d8e for PackagedProductDefinition 1645e915-e9b3-4b37-86e9-9031abb96410

Reimbursement SL 7c708109-5c46-443a-b6b6-8cdf827ca6b9 for PackagedProductDefinition 77b4e329-e8d2-466f-944b-2143379f3671

Fluoxetinum


Marketing Authorisation 57925 for MedicinalProductDefinition 2ce9a24f-41e5-4fd8-82aa-ebad8c213fa9

Fluoxetin Zentiva Disp Tabl 20 mg Blist 10 Stk

Fluoxetin Zentiva Disp Tabl 20 mg Blist 30 Stk

Fluoxetin Zentiva Disp Tabl 20 mg Blist 100 Stk

Marketing Authorisation 57925001-85df3abd-e250-4e6f-ac7a-2d0d6ccbbb43 for PackagedProductDefinition 85df3abd-e250-4e6f-ac7a-2d0d6ccbbb43

Marketing Authorisation 57925003-0658552b-c597-4cfb-a001-646c836b6a6f for PackagedProductDefinition 0658552b-c597-4cfb-a001-646c836b6a6f

Marketing Authorisation 57925005-bfeccd72-e390-42aa-836f-7529a599cc99 for PackagedProductDefinition bfeccd72-e390-42aa-836f-7529a599cc99

Reimbursement SL 78b1897e-d8ca-4d69-8a5e-910f32e4e243 for PackagedProductDefinition 85df3abd-e250-4e6f-ac7a-2d0d6ccbbb43

Reimbursement SL 735ce7ce-562d-4647-a989-8ee170673af7 for PackagedProductDefinition 0658552b-c597-4cfb-a001-646c836b6a6f

Reimbursement SL 16500781-598b-4e0a-8352-3b1fac11ac13 for PackagedProductDefinition bfeccd72-e390-42aa-836f-7529a599cc99

Fluoxetinum


Marketing Authorisation 54327 for MedicinalProductDefinition 76499c7b-5282-4827-bac0-7346abc99970

Fluoxetin Zentiva Kaps 20 mg Blist 30 Stk

Fluoxetin Zentiva Kaps 20 mg Blist 100 Stk

Marketing Authorisation 54327001-4405056f-4d14-43b4-b4fd-e2906face642 for PackagedProductDefinition 4405056f-4d14-43b4-b4fd-e2906face642

Marketing Authorisation 54327002-6ffcf7af-e919-46c3-a0f3-b1716d76dbb3 for PackagedProductDefinition 6ffcf7af-e919-46c3-a0f3-b1716d76dbb3

Reimbursement SL d7ec0572-45a9-4941-9d80-bd5c8d4a8d8e for PackagedProductDefinition 4405056f-4d14-43b4-b4fd-e2906face642

Reimbursement SL 51afa543-7f66-4f8f-a7db-bb8b9d3cc38c for PackagedProductDefinition 6ffcf7af-e919-46c3-a0f3-b1716d76dbb3

Fluoxetinum


12.02.30. Nasenmittel mit Corticosteroiden

Marketing Authorisation 69312 for MedicinalProductDefinition afef8666-bace-46b3-a5bf-a682308ec298

Fluticason-Mepha Nasenspray 27.5 mcg Spr 120 Dos

Marketing Authorisation 69312001-b0749849-d227-416a-b663-6424fc8e87e4 for PackagedProductDefinition b0749849-d227-416a-b663-6424fc8e87e4

Reimbursement SL a05dd82c-9fe0-4f8e-a766-8bd745f62b28 for PackagedProductDefinition b0749849-d227-416a-b663-6424fc8e87e4

Fluticasoni furoas


03.04.30. Sympathicomimetica und Parasympathicolytica

Marketing Authorisation 63032 for MedicinalProductDefinition 1d2a766c-07ef-463f-a7dd-6bcdae9c1363

Mundipharma Medical Company Hamilton,Bermuda,Basel Branch

Flutiform 125/5 Dosieraeros 120 Dos

Marketing Authorisation 63032002-0d32ff76-052f-4566-84b3-67850d00ddbf for PackagedProductDefinition 0d32ff76-052f-4566-84b3-67850d00ddbf

Reimbursement SL 21bbd7f0-1761-4191-9b2a-20fd5c16fb2e for PackagedProductDefinition 0d32ff76-052f-4566-84b3-67850d00ddbf

Fluticasoni-17 propionas

Formoteroli fumaras dihydricus


Marketing Authorisation 63032 for MedicinalProductDefinition ccfcb02f-9c16-4484-bbc2-2503e3f984f5

Flutiform 250/10 Dosieraeros 120 Dos

Reimbursement SL ad12c0b9-136a-4f82-b501-85b83c2e184b for PackagedProductDefinition bc79e8f8-2260-465f-9774-558521a878d3

Fluticasoni-17 propionas

Formoteroli fumaras dihydricus


Marketing Authorisation 63032 for MedicinalProductDefinition c1f136c6-bed1-4877-8417-231488283eba

Flutiform 50/5 Dosieraeros 120 Dos

Marketing Authorisation 63032001-3af3e1da-3aff-41c3-9e1b-4474ef755922 for PackagedProductDefinition 3af3e1da-3aff-41c3-9e1b-4474ef755922

Reimbursement SL d60625f1-4bec-4863-9bbc-b23d51a99550 for PackagedProductDefinition 3af3e1da-3aff-41c3-9e1b-4474ef755922

Fluticasoni-17 propionas

Formoteroli fumaras dihydricus